Rx – All 4

APPENDIX R: ORAL ANTICONVULSANT DRUGS
ANTICONVULSANT DRUGS WITH DOSE FORMS

brivaracetam (C)
Briviact Tab: 10, 25, 50, 75, 100 mg; Oral soln: 10 mg/ml (300 ml); Vial: 50 mg/
5 ml single-dose for IV inj
carbarbamazepine (D)(G)
Carbatrol Cap: 200, 300 mg ext-rel
Equetro Cap: 100, 200, 300 mg ext-rel
Tegretol Tab: 100*, 200*mg; Chew tab: 100*mg
Tegretol Suspension Oral susp: 100 mg/5 ml (450 ml) (citrus vanilla) (sorbitol)
Tegretol-XR Tab: 100, 200, 400 mg ext-rel
clobazam (C)(IV)
Onfi Tab: 10*, 20*mg
Onfi Oral Suspension Oral susp: 2.5 mg/ml (120 ml w. 2 dosing syringes)
(berry)
clonazepam (D)(IV)(G)
Clonazepam ODT ODT: 0.125, 0.25, 0.5, 1, 2, oral-dis
Klonopin Tab: 0.5*, 1, 2 mg
diazepam (D)(IV)(G)
Diastat Rectal gel delivery system: 2.5 mg
Diastat AcuDial Rectal gel delivery system: 10, 20 mg
Valium Tab: 2*, 5*, 10*mg
Valium Injectable Vial: 5 mg/ml (10 ml); Amp: 5 mg/ml (2 ml); Prefi lled
syringe: 5 mg/ml (5 ml)
Valium Intensol Conc oral soln: 5 mg/ml (30 ml w. dropper) (alcohol 19%)
Valium Oral Solution Oral soln: 5 mg/5 ml (500 ml) (winter green-spice)
divalproex sodium (D)(G)
Depakene Cap: 250 mg; Syr: 250 mg/5 ml (16 oz)
Depakote Tab: 125, 250, 500 mg
Depakote ER Tab: 250, 500 mg ext-rel
Depakote Sprinkle Cap: 125 mg
eslicarbazepine (C)
Aptiom Tab: 200*, 400, 600*, 800* mg
ezogabine (C)
Potiga Tab: 50, 200, 300, 400 mg
felbamate (C)(G)
Felbatol Tab: 400*, 600*mg
Felbatol Oral Suspension Oral susp: 600 mg/5 ml (4, 8, 32 oz)
Peganone Tab: 250, 500 mg
bapentin (C)
Horizant Tab: 300, 600 ext-rel
Neurontin (G) Cap: 100, 300, 400 mg; Tab: 600*, 800*mg
Neurontin Oral Solution Oral soln: 250 mg/5 ml (480 ml) (strawberry-anise)
lacosamide (C)(V)(G)
Vimpat Tab: 50, 100, 150, 200 mg; Oral soln: 10 mg/ml (200, 465 ml); Vial:
10 mg/ml soln for IV infusion, single-use (20 ml)
lamotrigine (C)(G)
Lamictal Tab: 25*, 100*, 150*, 200*mg
Lamictal Chewable Dispersible Tab Chew tab: 2, 5, 25, 50 mg (black current)
Lamictal ODT ODT: 25, 50, 100, 200 mg oral-dis
Lamictal XRTab: 25, 50, 100, 200, 250, 300 mg ext-rel
levetiracetam (C)
Elepsia Tab: 1000, 1500 mg ext-rel
Keppra Tab: 250*, 500*, 750*, 1000*mg
Keppra Oral Solution Oral soln: 100 mg/ml (16 oz) (grape) (dye-free)
Keppra XR Tab: 500, 750 mg ext-rel
Levitiracetam IV (G) Premixed: 500, 1,000, 1,500 mg for IV infusion (100 ml)
mephobarbital (D)(II)
Mebaral Tab: 32, 50, 100 mg
methsuximide (C)
Celontin Kapseals Cap: 150, 300 mg
oxcarbazepine (C)(G)
Trileptal Tab: 150, 300, 600 mg; Oral susp: 300 mg/5 ml (lemon) (alcohol)
Oxtella XR Tab: 150, 300, 600 mg ext-rel
perampanel (C)(III)
Fycompa Tab: 2, 4, 6, 8, 10, 12 mg
Fycompa Oral Suspension Oral susp: 0.5 mg/ml (340 ml w. dosing syringe)
phenytoin (D)(G), primidone (D)(G)
Dilantin Cap: 30, 100 mg ext-rel
Dilantin Infatabs Chew tab: 50 mg
Dilantin Oral Suspension Oral susp: 125 mg/5 ml (237 ml) (alcohol 6%)
Phenytek Cap: 200, 300 mg ext-rel
pregabalin (C)(V)
Lyrica Cap: 25, 50, 75, 100, 200, 225, 300 mg
Lyrica Oral Solution Oral soln: 20 mg/ml
primidone (C)
Mysoline Tab: 50*, 250*mg
Mysoline Oral Solution Oral susp: 250 mg/5 ml (8 oz)
rufi namide (C)(G)
Banzel Tab: 200*, 400*mg
Banzel Oral Solution Susp: 40 mg/ml (orange) (lactose-free, gluten-free,
dye-free)
tiagabine (C)(G)
Gabitril Tab: 2, 4, 12, 16 mg
topiramate (D)(G)
Topamax Tab: 25, 50, 100, 200 mg
Topamax Sprinkle Caps Cap: 15, 25, 50 mg
Trokendi XR Cap: 100, 200 mg ext-rel
Qudexy Tab: 25, 50, 100, 150, 200 mg ext-rel
Qudexy XR Cap: 25, 50, 100, 150, 200 mg ext-rel
vigabatrin (C)
Sabril Tab: 500 mg
Sabril for Oral Solution 500 mg/pkt pwdr for reconstitution
zonisamide (C)
Zonegran Cap: 25, 50, 100 mg
Aptivus (C) tipranavir
Gel cap: 250 mg (alcohol); Oral soln: 100 mg/ml (95 ml w. dosing syringe) (Vit E
116 IU/ml) (buttermint-butter, toff ee)
Comment: valganciclovir is indicated for the treatment of AIDS-related
cytomegalovirus (CMV) retinitis.
Atripla (D) efavirenz/emtricitabine/tenofovir disoproxil
Tab: efa 600 mg/emtri 200 mg/teno diso 300 mg
Combivir (C)(G) lamivudine/zidovudine
Tab: aba/lami 150/zido 300 mg
Complera (B) emtricitabine/tenofovir disoproxil fumarate/
rilpivirine
Tab: emtri 200 mg/teno diso 300 mg/rilpiv 25 mg
Crixivan (C) indinavir sulfate
Cap: 100, 200, 333, 400 mg
Cytovene (C)(G) ganciclovir
Cap: 250, 500 mg; Vial: 50 mg/ml single-dose (500 mg, 10 ml)
Descovy (D) emtricitabine/tenofovir alafenamide/rilpivirine
Tab: emtri 200 mg/teno ala 25 mg
Edurant (B) rilpivirine
Tab: 25 mg
Emtriva (B) emtricitabine
Cap: 200 mg; Oral soln: 10 mg/ml (170 ml) (cotton candy)
Epivir (C)(G) lamivudine
Tab: 150*, 300*mg; Oral soln: 10 mg/ml (240 ml) (strawberry-banana) (sucrose
3 g/15 ml)
Epzicom (B) abacavir sulfate/lamivudine
Tab: aba 600 mg/lami 300 mg
(continued)
APPENDIX S: ORAL ANTI-HIV DRUGS WITH
DOSE FORMS
Evotaz (B) atazanavir/cobicistat
Tab: ataz 300/cobi 150 mg
Fortovase (B) aquinavir
Soft gel cap: 200 mg
Fuzeon (B) enfuvirtide
Vial: 90 mg/ml pwdr for SC inj aft er reconstitution (1 ml, 60 vials/kit)
(preservative-free)
Genvoya (B) elvitegravir/cobicistat/emtricitabine/tenofovir
alafenamide (TAF)
Tab: elv 150 mg/cob 150 mg/emtri 200 mg/teno alafen 10 mg
Intelence (C) etravirine
Tab: 25*, 100, 200 mg
Invirase (B) saquinavir mesylate
Hard gel cap: 200 mg
Isentress (C) raltegravir (potassium)
Tab: 400 mg fi lm-coat; Chew tab: 25, 100*mg (orange-banana) (phenylalanine);
Oral susp: 100 mg/pkt pwdr for oral susp (banana)
Kaletra (C) lopinavir plus ritonavir
Cap: lopin 100 mg/riton 25 mg, lopin 200 mg/riton 50 mg; Oral soln: lopin 80 mg/
riton 20 mg per ml (160 ml w. dose cup) (cotton candy) (alcohol 42%)
Hard gel cap: 200 mg
Lexiva (C)(G) fosamprenavir
Tab: 700 mg; Oral soln: 50 mg/ml (grape, bubble gum) (peppermint)
Norvir (B) ritonavir
Soft gel cap: 100 mg (alcohol); Oral soln: 80 mg/ml (8 oz) (peppermint-caramel)
(alcohol)
Odefsey (D) emtricitabine/rilivirine/tenofovir alafenamide
Tab: emtri 200 mg/rilpiv 25 mg/tenof alafen 25 mg
Prezcobix (B) darunavir/cobicistat
Tab: daru 800/cobi 150 mg
Prezista (C) darunavir
Tab: 75, 150, 600, 800 mg; Oral susp: 100 mg/ml (200 ml) (strawberry cream)
Rescriptor (C) delavirdine mesylate
Tab: 100, 200 mg
Retrovir (C)(G) zidovudine
Tab: 300 mg; Cap: 100 mg; Syr: 50 mg/5 ml (240 ml) (strawberry); Vial: 10 mg/
ml (20 ml vial for IV infusion) (peservative-free)
Reyataz (B) atazanavir
Cap: 100, 150, 200, 300 mg
Selzentry (B) maraviroc
Tab: 150, 300 mg
Stribild (B) elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil
fumarate
Tab: elv 150 mg/cob 150 mg/emtri 200 mg/teno diso fumar 300 mg
Sustiva (C) efavirenz
Tab: 75, 150, 600, 800 mg; Cap: 50, 200 mg
Tivicay (B) dolutegavir
Tab: 50 mg
Triumeq (C) abacavir sulfate/dilutegravir/lamivudine
Tab: aba 600 mg/dilu 50 mg/lami 300 mg
Trizivir (C)(G) abacavir sulfate/lamivudine/zidovudine
Tab: aba 300 mg/lami 150 mg/zido 300 mg
Truvada (B) emtricitabine/tenofovir disoproxil fumarate
Tab: emt 100 mg/teno 150 mg, 133 mg/teno 200 mg, emt 167 mg/teno 250 mg,
emt 200 mg/teno 300 mg
Valcyte (C)(G) valganciclovir
Tab: 450 mg
Videx EC (C)(G) didanosine
Cap: 125, 200, 250, 400 mg ent-coat del-rel; Chew tab: 25, 50, 100, 150, 200 mg
(mandarin orange; buff ered with calcium carbonate and magnesium hydroxide,
phenylalanine); Pwdr for oral soln: 2, 4 g (120, 240 ml)
(continued)
(continued)
Videx Pediatric Pwdr for Oral Solution (C) didanosine
Pwdr for oral soln: 2, 4 g (120, 240 ml)
Viracept (B) nelfinavir mesylate
Tab: 250, 625 mg; Pwdr for oral soln: 50 mg/g (144 g) (phenylalanine)
Viramune (C)(G) nevirapine
Tab: 200*mg; Oral susp: 50 mg/5 ml (240 ml)
Viramune XR (C) nevirapine
Tab: 100, 400 mg ext-rel
Viread (C) tenofovir disoproxil fumarate
Tab: 150, 200, 250, 300 mg; Oral pwdr: 40 mg/1 g pwdr (60 g w. dosing scoop)
Vistide (C) cidofovir
Inj: 75 mg/ml (5 ml vials for IV infusion) (preservative free)
Comment: cidofovir is indicated for the treatment of AIDS-related cytomegalovirus
(CMV) retinitis.
Vitekta (C) elvitegravir
Inj: 75 mg/ml (5 ml vials for IV infusion) (preservative free)
Comment: cidofovir is indicated for the treatment of AIDS-related cytomegalovirus
(CMV) retinitis.
Zerit (C)(G) stavudine
Cap: 15, 20, 30, 40 mg; Oral soln: 1 mg/ml pwdr for reconstitution (200 ml)
(fruit) (dye-free)
Ziagen (C)(G) abacavir sulfate
Tab: 300*mg; Oral soln: 20 mg/ml (240 ml) (strawberry-banana) (parabens,
propylene glycol)
(continued)
(continued)
t APPENDIX T: COUMADIN (WARFARIN)
T.1: COUMADIN TITRATION AND DOSE FORMS
warfarin (X)(G) dosage initially 2-5 mg/day; usual maintenance 2-10 mg/day;
adjust dosage to maintain INR in therapeutic range:
Venous thrombosis: 2.0-3.0
Atrial fi brillation: 2.0-3.0
Post MI: 2.5-3.5
Mechanical and bioprosthetic heart valves: 2.0-3.0 for 12 weeks aft er valve insertion,
then 2.5-3.5 long-term
Pediatric: not recommended <18 years
Coumadin Tab: 1*, 2*, 2.5*, 3*, 4*, 5*, 6*, 7.5*, 10* mg
Coumadin for Injection Vial: 2 mg/ml (2.5 ml)
Comment: Coumadin for Injection is for peripheral IV administration only.
T.2: COUMADIN OVER-ANTICOAGULATION REVERSAL
phytonadione (vitamin K) (G) 2.5-10 mg PO or IM; max 25 mg
AquaMEPHYTON
Vial: 1 mg/0.5 ml (0.5 ml); 10 mg/ml (1, 2.5, 5 ml)
Mephyton
Tab: 5 mg
T.3: AGENTS THAT INHIBIT COUMADIN’S ANTICOAGULATION EFFECTS
Increase Metabolism Decrease Absorption Other Mechanism(s)
azathioprine
carbamazepine
dicloxacillin
ethanol
griseofulvin
nafcillin
pentobarbital
phenobarbital
phenytoin
primidone
rifabutin
rifampin
azathioprine
cholestyramine
colestipol
sucralfate
coenzyme Q10
estrogen
griseofulvin
oral contraceptives
ritonavir
spironolactone
trazodone
vitamin C (high
dose)
vitamin K
y
(continued)
(continued)
t APPENDIX U: LOW MOLECULAR WEIGHT HEPARINS
Comment: Administer by subcutaneous injection only, in the abdomen,
and rotate sites. Avoid concomitant drugs that aff ect hemostasis (e.g., oral
anticoagulants and platelet aggregation inhibitors, including aspirin, NSAIDs,
dipyridamole, sulfi npyrazone, ticlopidine). Pediatrics not recommended.
ardeparin (C)
Normifl o Soln for inj: 5,000 anti-Factor Xa U/0.5 ml; 10,000 anti-Factor Xa
U/0.5 ml (sulfi tes, parabens)
dalteparin (B)
Fragmin Prefi lled syringe: 2500 IU/0.2 ml, 5000 IU/0.2 ml (10/box) (preservative-
free); Multi-dose
vial: 1,000 IU/ml (95,000 IU, 9.5 ml) (benzyl alcohol)
danaparoid (B)
Orgaran Amp: 750 anti-Xa units/0.6 ml (0.6 ml, 10/box); Prefi lled syringe:
750 anti-Xa units/0.6 ml (0.6 ml, 10/box) (sulfi tes)
enoxaparin (B)(G)
Lovenox Prefi lled syringe: 30 mg/0.3 ml, 40 mg/0.4 ml, 60 mg/0.6 ml,
80 mg/0.8 ml (100 mg/ml)
(preservative-free); Vial: 100 mg/ml (3 ml)
tinzaparin (B)
Innohep Vial: 20,000 anti-Factor Xa IU/ml (2 ml) (sulfi tes, benzyl alcohol)
apixaban (C) 5 mg bid; reduce to 2.5 mg bid if any two of the following: =80 years,
=60 kg, serum Cr =1.5
Pediatric: not recommended
Eliquis Tab: 2.5, 5 mg
Comment: Eloquis is indicated to reduce the risk of stroke and systemic
embolism in patients with nonvalvular atrial fi brillation (NVAF).
edoxaban (C) transition to and from Savaysa; assess CrCl prior to initiation:
NVAF CrCl >50 mL/min: 60 mg once daily; CrCl 15-50 mL/min: 30 mg once daily
DVT/PE CrCl >50 mL/min: 60 mg once daily following initial parental anticoagulant;
CrCl 15-50 mL/min, <60 kg, or concomitant Pgp inhibitors: 30 mg once daily
Pediatric: not established
Savaysa Tab: 15, 30, 60 mg
Comment: Savaysa is indicated to reduce the risk of stroke and systemic
embolism in patients with nonvalvular atrial fi brillation (NVAF), treatment
of DVT and pulmonary embolism (PE) following 5-10 days of initial therapy
with with parenteral anticoagulant. Not for use in persons with NVAF with
CrCl >95 mL/min.
fondaparinux (B) Administer SC; administer fi rst dose no earlier than 6-8 hours
aft er hemostasis is achieved, start warfarin usually within 72 hours of last dose of
fondaparinux
APPENDIX V: FACTOR XA INHIBITOR THERAPY
FACTOR XA INHIBITOR THERAPY

Post-op: 2.5 mg once daily x 5-9 days
Hip/Knee Replacement: once daily x 11 days
Hip Fracture: once daily x 32 days
Abdominal Surgery: once daily x 10 days
Prophylaxis: do not use <50 kg
Treatment: once daily for at least 5 days until INR=2-3 (usually 5-9 days); max
26 days; <50 kg: 5 mg; 50-100 kg: 7.5 mg; >100 kg: 10 mg
Pediatric: not established
Arixtra Soln for SC inj: 2.5 mg/0.5 ml, 5 mg/0.4 ml, 7.5 mg/0.6 ml, 10 mg/
0.8 ml prefi lled syringe (10/box) (preservative-free)
prasugrel (B) Loading dose: 60 mg once in a single-dose; Maintenance: 10 mg once
daily; <60 kg: consider 5 mg once daily; take with aspirin 75-325 mg once daily
Pediatric: not recommended
Effi ent Tab: 5, 10 mg
Comment: Effi ent is indicated to reduce the risk of thrombotic cardiovascular
events in persons with acute coronary syndrome (ACS) who aret to be
managed with percutaneous coronary intervention (PCI) including unstable
angina, non-ST elevation myocardial infarction (NSTEMI) and STEMI.
Do not start if active pathological bleeding (e.g., peptic ulcer, intracranial
hemorrhage), prior TIA or stroke, or if patient likely to undergo urgent
CABG. Discontinue 7 days before surgery and if TIA or stroke occurs.
rivaroxaban (C) take with food
Treatment of DVT or PE: 15 mg twice daily for the fi rst 21 days; then 20 mg once
daily
Reduction in risk of DVT or PE recurrence: 20 mg once daily with the evening
meal; CrCl <30 mL/min: avoid
Prophylaxis of DVT: take 6-10 hours aft er surgery when hemostasis established,
then 20 mg once daily with the evening meal; CrCl 30-50 mL/min: 10 mg; CrCl
<30 mL/min: avoid; discontinue if acute renal failure develops; monitor closely
for
blood loss
Hip: treat for 35 days; Knee: treat for 12 days
Nonvalvular AF: take once daily with the evening meal; CrCl >50 mL/min: 20 mg;
CrCl 15-50 mL/min: 15 mg; CrCl >15 mL/min: avoid
Pediatric: not recommended
Xarelto Cap: 10, 15, 20 mg
Comment: Xarelto is indicated to reduce the risk of stroke and systemic
embolism in nonvalvular atrial fi brillation (AF), to treat deep vein
thrombosis (DVT) and pulmonary embolism (PE), to reduce the risk of
recurrence of DVT and/or PE following 6 months treatment for DVT and/
or PE, and prophylaxis of DVT which may lead to PE in patients undergoing
knee or hip replacement surgery. Xarelto eliminates the need for bridging
with heparin or lmwh; no need for routine monitoring of INR or other
coagulation parameters; no need for dose adjustments for age, weight, or
gender; no known dietary restrictions. Switching from warfarin or other
anticoagulant, see mfr pkg insert.
aspirin (D) single dose once daily
Pediatric: not established
Durlaza Cap: 162.5 mg 24-hr ext-rel (30, 90/bottle)
Comment: Presently there is only one reversal agent for this drug class.
idarucizumab (Praxbind) is a specifi c reversal agent for dabigatran (Pradaxa).
It is a humanized monoclonal antibody fragment (Fab) that binds to
dabigatran and its acylglucuronide metabolites with higher affi nity than the
binding affi nity of dabigatran to thrombin, neutralizing its anticoagulant
eff ects.
IDARUCIZUMAB REVERSAL AGENT: HUMANIZED MONOCLONAL
ANTIBODY FRAGMENT (FAB)
idarucizumab (NE) administer 5 g (2 vials) IV drip or push; administer within 1
hour of removal from vial
Pediatric: not established
Praxbind Vial: 2.5 g/50 ml, single-use (preservative-free)
Comment: Presently, there is inadequate human and animal data to assess
risk of idarucizumab (Praxbind) use in pregnancy. Risk/benefi t should be
considered prior to use.
dabigatran etexilate mesylate (C) swallow whole; CrCl >30 mL/min: 150 mg bid;
CrCl 15-30 mL/min: 75 mg twice daily; CrCl <15 mL/min: not recommended
Pediatric: not recommended
Pradaxa Cap: 75, 150 mg
Comment: Pradaxa is indicated to reduce the risk of stroke and systemic
embolism in nonvalvular AF, DVT prophylaxis, PE prophylaxis in patients
who have undergone hip replacement surgery, treatment of DVT and PE in
patients who have been treated with a parenteral anticoagulant for 5-10 days,
and to reduce the risk of recurrent DVT and PE in patients who have been
previously treated. Pradaxa is contraindicated in patients with a mechanical
prosthetic heart valve.
desirudin (recombinant hirudin) (C) 15 mg SC every 12 hours, preferably in the
abdomen or thigh, starting up to 5-15 minutes before surgery (aft er induction of
regional block anesthesia, if used); may continue for 9-12 days post-op; CrCl <60
mL/min: reduce dose (see mfr pkg insert)
Pediatric: not recommended
Iprivask Pwdr for SC inj aft er reconstitution: 15mg/single-use vial (10/box)
(preservative-free, diluent contains mannitol)
Comment: Iprivask is indicated for DVT prophylaxis in patients
undergoing hip replacement surgery. It is not interchangeable with other
hirudins.
cilostazol (B) 100 mg bid
Pediatric: not recommended
Pletal Tab: 50, 100 mg
Comment: Pletal is an (antiplatelet/vasodilator [PDE III inhibitor])
clopidogrel (B) 75 mg once daily
Pediatric: not recommended
Plavix Tab: 75, 300 mg
Comment: Plavix is indicated for the reduction of atherosclerotic events
in recent MI or stroke, established PAD, non-ST-segment elevation acute
coronary syndrome (unstable angina/non-STEMI), or STEMI.
dipyridamole (B)(G) 75-100 mg qid
Pediatric: not recommended
Persantine Tab: 25, 50, 75 mg
Comment: dipyridamole is indicated as an adjunct to oral anticoagulants aft er
cardiac valve replacement surgery to prevent thromboembolism.
dipyridamole/aspirin (B)(G) swallow whole; one cap bid
Pediatric: not recommended
Aggrenox Cap: dipyr 200 mg/asa 25 mg
pentoxifylline (C) [hemorrheologic (xanthine)] Pediatric: not recommended
Trental Tab: 400 mg sust-rel
prasugrel (C)
Pediatric: not recommended
Effi ent Tab: 5, 10 mg
Comment: Effi ent is indicated to reduce the risk of cardiovascular events in
patients with acute coronary syndrome (ACS) who are to be managed with
percutaneous coronary intervention (unstable angina or non-STEMI), and
STEMI when managed with either primary or delayed PCI.
ticagrelor (C) initiate 180 mg loading dose once in a single dose with aspirin 325
mg loading dose in a single dose; maintenance 90 mg twice daily with aspirin
75-100 mg once daily; ACS patients may start ticagrelor aft er a loading dose of
clopidogrel
Brilinta Tab: 90 mg
Comment: Effi ent is indicated to reduce the risk of cardiovascular events
in patients with acute coronary syndrome (ACS) (unstable angina, Non-ST
elevation (NSTEMI), myocardial infarction, or STEMI).
ticlopidine (B) 250 mg bid
Pediatric: not recommended
Ticlid Tab: 250 mg
Comment: Ticlid is indicated to reduce the risk of thrombotic stroke in
selected patients intolerant of aspirin.
vorapaxar (B) administer 2.08 mg once daily; use with aspirin or clopidogrel
Pediatric: not established
Zontivity Tab: 2.08 mg (equivalent to 2.5 mg vorapaxar sulfate)
Comment: Zontivity is indicated to reduce thrombotic cardiovascular events
in patients with a history of myocardial infarction or with peripheral arterial
disease (PAD). Contraindicated with active pathological bleeding (e.g., peptic
ulcer, intra-cranial hemorrhage), prior TIA or stroke. Not recommended
with severe hepatic impairment.
y
t APPENDIX Z: PRESCRIPTION PRENATAL VITAMINS
Comment: It is recommended that prenatal vitamins be started at least 3 months
prior to conception to improve preconception nutritional status, and continued
throughout pregnancy and the postnatal period, in lactating and nonlactating
women, and throughout the childbearing years.
CitraNatal 90 DHA take 1 tab* and 1 DHA cap daily
Tab: thiamine 3 mg, ribofl avin 3.4 mg, niacinamide 20 mg, pyridoxine HCL 20
mg, folic acid 1 mg, Vit C 120 mg, Vit D3 400 IU, Vit E 30 IU, calcium (as citrate)
160 mg, copper (as oxide) 2 mg, iodine (as potassium iodide) 150 mcg, iron (as
carbonyl) 90 mg, zinc (as oxide) 25 mg, docusate sodium 50 mg
Cap: docosahexaenoic acid (DHA) 300 mg
CitraNatal Assure take 1 tab and 1 DHA cap daily
Tab: thiamine 3 mg, ribofl avin 3.4 mg, niacinamide 20 mg, pyridoxine HCL 25 mg,
folic acid 1 mg, Vit C 120 mg, Vit D3 400 IU, Vit E 30 IU, calcium (as citrate) 125
mg, copper (as oxide) 2 mg, iodine (as potassium oxide) 150 mcg, iron (as carbonyl
and ferrous gluconate) 35 mg, zinc (as oxide) 25 mg, docusate sodium 50 mg
Cap: docosahexaenoic acid (DHA) 300 mg
CitraNatal B-Calm take 1 tab every 8 hours; begin with tab #1.
Tab: pyridoxine HCL 25 mg, folic acid 1 mg, Vit C 120 mg, Vit D3 400 IU, calcium
(as citrate) 120 mg, iron (as carbonyl) 20 mg
Tab: pyridoxine 25 mg
Comment: Citranatal B-Calm may be used as an adjunct treatment to help
minimize pregnancy-related nausea and vomiting.
CitraNatal DHA take 1 tab and 1 DHA cap daily
Tab: thiamine 3 mg, ribofl avin 3.4 mg, niacinamide 20 mg, pyridoxine HCL 20
mg, folic acid 1 mg, Vit C 120 mg, Vit D3 400 IU, Vit E 30 IU, calcium (as citrate)
125 mg, copper (as oxide) 2 mg, iodine (as potassium oxide) 150 mcg, iron (as
carbonyl and gluconate) 27 mg, zinc (as oxide) 25 mg, docusate sodium 50 mg
Cap: docosahexaenoic acid (DHA) 250 mg
CitraNatal Harmony take 1 gelcap daily
Gelcap: pyridoxine HCL 25 mg, folic acid 1 mg, Vit D3 400 IU, Vit E 30 IU, calcium
(as citrate) 104 mg, iron (as carbonyl and ferrous fumarate) 27 mg, docusate
sodium 50 mg, docosahexaenoic acid (DHA) 260 mg
CitraNatal Rx take 1 tab* and 1 DHA cap daily
Tab: thiamine 3 mg, ribofl avin 3.4 mg, niacinamide 20 mg, pyridoxine HCL 20
mg, folic acid 1 mg, Vit C 120 mg, Vit D3 400 IU, Vit E 30 IU, calcium (as citrate)
125 mg, copper (as oxide) 2 mg, iodine (as potassium iodide) 150 mcg, iron (as
carbonyl and gluconate) 27 mg, zinc (as oxide) 25 mg, docusate sodium 50 mg
Duet DHA Balanced take 1 tab and 1 gelcap daily
Tab: Vit A (as beta carotene) 2800 IU, thiamine 1.5 mg, ribofl avin 2 mg,
niacinamide 20 mg, pyridoxine HCL 50 mg, Vit B12 12 mcg, folic acid 1 mg,
Vit C 120 mg, Vit D3 640 IU, Vit E 15 IU, calcium (as carbonate) 215 mg, iron
(as polysaccharide iron complex and sodium iron EDTA, Ferrazone) 25 mg,
copper (as oxide) 1.8 mg, magnesium (as oxide) 25 mg, zinc (as oxide) 25 mg,
iodine (as potassium iodide) 210 mcg, selenium 65 mcg, choline (as bartrate)
55 mg
Gelcap: omega 3 fatty acids 267 mg (includes docosahexaenoic acid [DHA],
eicosapentaenoic acid [EPA], alpha-linolenic acid [ALA], docasapentaeoic acid
[DPA]) (gelatin, gluten-free)
Duet DHA Complete take 1 tab and 1 gelcap daily
Tab: Vit A (as beta carotene) 3000 IU, thiamine 1.8 mg, ribofl avin 4 mg, niacinamide
20 mg, pyridoxine HCL 50 mg, Vit B12 12 mcg, folic acid 1 mg, Vit C 120
mg, Vit D3 800 IU, Vit E 3 mg, calcium (as carbonate) 230 mg, iron (as polysaccharide
iron complex and sodium iron EDTA, ferrazone) 27 mg, copper (as
oxide) 2 mg, magnesium (as oxide) 25 mg, zinc (as oxide) 25 mg, iodine 220 mcg
Gelcap: omega 3 fatty acids =430 mg (as docosahexaenoic acid (DHA) =295 mg,
as other omega-3 fatty acids =135 mg (eicosapentaenoic acid (EPA), docasapentaenoic
acid (DHA) (gluten-free)
Natachew take 1 chew tab daily
Chew tab: Vit A 1000 IU (as beta carotene), thiamine 2 mg, ribofl avin 3 mg,
niacinamide 20 mg, pyridoxine HCL 10 mg, B12 12 mcg, folic acid 1 mg,
Vit C 120 mg, Vit D3 400 IU, Vit E 11 IU, iron (as ferrous fumarate) 29 mg
(wildberry)
Natafort take 1 tab daily
Tab: Vit A 1000 IU (as acetate and beta carotene), thiamine 2 mg, ribofl avin 3
mg, niacinamide 20 mg, pyridoxine HCL 10 mg, B12 12 mcg, folic acid 1 mg, Vit
C 120 mg, Vit D3 400 IU, Vit E 11 IU, iron (as carbonyl and sulfate) 60 mg
Neevo DHA take 1 cap daily
Cap: l-methylfolate (as Metafolin) 1.3 mg, thiamin1.4 mg, ribofl avin 1.4 mg,
niacinamide 18 mg, pyridoxine HCL 25 mg, B12 1 mg, Vit C 85 mg, Vit D3, 5 mcg,
Vit E 15 IU, calcium (as carbonate) 110 mg, iron (ferrous fumarate) 27 mg, iodine
(as potassium iodide) 220 mcg, magnesium (as oxide) 60 mg, docosahexaenoic
acid (DHA, vegetarian source (algal oil) 581.92 mg (soy, gelatin, sorbitol, glycerin)
Comment: Neevo DHA is indicated as a nutritional supplement during
pregnancy, and the prenatal and postnatal periods, in women with dietary needs
for the biologically active form of folate, who are at risk for hyperhomocysteinemia,
impaired folic acid absorption, and/or impaired folic acid metabolism
due to 667C >T mutations in the MTHFR gene.
Nexa Plus take 1 cap daily
Cap: pyridoxine HCL 25 mg, folic acid 1.25 mg, Vit C 28 mg, Vit D3 800 IU, Vit
E 30 IU, biotin 250 mcg, calcium (as carbonate [158 mg] + docusate calcium
[2 mg] 160 mg, iron (as ferrous fumarate) 29 mg, docosahexaenoic acid (DHA,
plant-based source [algal oil]) 350 mg (soy)
Nexa Select take 1 soft gel cap daily
Soft gel cap: pyridoxine HCL 25 mg, folic acid 1.25 mg, Vit C 28 mg, Vit D3 800
IU, Vit E 30 IU, calcium (as phosphate) 160 mg, iron (as ferrous fumarate) 29
mg, docosahexaenoic acid (DHA) plant-based source (algal oil) 325 mg, docusate
sodium 55 mg (soy)
Prenate AM take 1 tab daily
Tab: pyridoxine HCL 75 mg, folate (as folic acid 400 mcg + Quatrefolic 1.1 mg
[equivalent to 600 mcg folic acid]) 1 mg, Vit B12 12 mcg, calcium (as carbonate)
200 mg, ginger extract 500 mg, lingon-berry 25 mg
Prenate Chewable take 1 chew tab daily
Chew tab: pyridoxine HCL 10 mg, Vit B12 125 mcg, calcium (as carbonate) 500
mg, Vit D3 300 IU, biotin 280 mcg, boron amino acid chelate 250 mcg, folate (as
Quatrefolic) 1 mg, magnesium (as oxide) 50 mg, blueberry extract 25 mg (Dutch
chocolate)
Prenate DHA take 1 gel cap daily
Gelcap: pyridoxine HCL 26 mg, folate (as folic acid) 400 mcg + Quatrafolic 1.1
mg [equivalent to 600 mcg folic acid]) 1 mg, Vit B12 13 mcg, Vit C 90 mg, Vit D3
220 IU, Vit E 10 IU, calcium (as carbonate) 145 mg, iron (as ferrous fumarate) 28
mg, magnesium (as oxide) 50 mg, docosahexaenoic acid (DHA) 300 mg (fi sh oil,
soy, gelatin)
Prenate Elite take 1 gel cap daily
Gelcap: Vit A (as beta-carotene) 2600 IU, thiamine 3 mg, ribofl avin 3.5 mg, pyridoxine
HCl 21 mg, niacinamide 21 mg, pantothenic acid 6 mg, folate (as folic
acid 400 mcg + Quatrefolic 1.1 mg [equivalent to 600 mcg folic acid]) 1 mg, Vit
B12 13 mcg, Vit C 75 mg, Vit D3 450 IU, Vit E 10 IU, biotin 330 mcg, calcium (as
carbonate) 100 mg, iron (as ferrous fumarate) 27 mg, magnesium (as oxide) 25
mg, copper (as oxide) 1.5 mg, iodine 150 mcg, iron (as ferrous fumarate) 26 mg,
zinc (as oxide) 15 mg
Prenate Enhance take 1 gel cap daily
Gelcap: pyridoxine HCL 25 mg, folate (as folic acid 400 mcg + Quatrefolic 1.1 mg
[equivalent to 600 mcg folic acid]) 1 mg, Vit B12 12 mcg, Vit C 85 mg, Vit D3 1000
IU, Vit E 10 IU, biotin 500 mcg, calcium (as carbonate + Formical) 155 mg, iodine
(as potassium) 150 mcg, iron (as ferrous fumarate) 28 mg, magnesium (as oxide)
50 mg, docosahexaenoicacid (DHA) 400 mg (soy, gelatin)
Prenate Essential take 1 gel cap daily
Gelcap: pyridoxine HCL 26 mg, folate (as folic acid 400 mcg + Quatrefolic 1.1
mg [equivalent to 600 mcg folic acid]) 1 mg, Vit B12 13 mcg, Vit C 90 mg, Vit
D3 220 IU, Vit E 10 IU, biotin 280 mcg, calcium (as carbonate) 145 mg, iodine
(as potassium iodide) 150 mcg, iron (as ferrous fumarate) 29 mg, magnesium
(as oxide) 50 mg, docosahexaenoic acid (DHA) 300 mg, eicosapentaenoic acid
(EPA) 40 mg (fi sh oil, soy, gelatin)
Prenate Mini take 1 gel cap daily
Gelcap: pyridoxine HCL 26 mg, folate (as folic acid) 400 mcg + Quatrefolic 1.1 mg
[equivalent to 600 mcg folic acid]) 1 mg, Vit B12 13 mcg, Vit C 60 mg, Vit D3 220 IU,
Vit E 10 IU, calcium (as carbonate) 100 mg, iron (as carbonyl iron) 29 mg, iodine
(as potassium iodide) 150 mcg, biotin 280 mcg, magnesium (as oxide) 25 mg, docosahexaenoic
acid (DHA) 300 mg, blueberry extract 25 mg (fi sh oil, soy, gelatin)
Prenate Restore take 1 gel cap daily
Gelcap: pyridoxine HCL 25 mg, folate (as folic acid 400 mcg + Quatrefolic 1.1
mg [equivalent to 600 mcg folic acid]) 1 mg, Vit B12 12 mcg, Vit C 85 mg, Vit D3
1000 IU, Vit E 10 IU, biotin 500 mcg, calcium (as carbonate + Formical) 155 mg,
iron (as ferrous fumarate) 27 mg, magnesium (as oxide) 45 mg, docosahexaenoic
acid (DHA) 400 mg, Bacillus coagulans 150 million CFU (as lactospore) 10 mg
(soy, gelatin)
Prenexa take 1 gel cap daily
Gelcap: pyridoxine HCL 25 mg, folic acid 1.25 mg, Vit C 28 mg, Vit D3 400 IU,
Vit E 30 IU, calcium (as phosphate) 160 mg, iron (as ferrous fumarate) 27 mg,
docosahexaenoic acid (DHA) plant-based source (algal oil) 300 mg, docusate
sodium 55 mg (soy)
APPENDIX AA: ORAL PRESCRIPTION DRUGS
FOR THE MANAGEMENT OF ALLERGY, COUGH,
AND COLD SYMPTOMS
Oral prescription drugs for the management of allergy symptoms, cough, and symptoms
of the common cold are listed in alphabetical order by brand name.
Legend: acriv acrivastine
benzo benzonatate
brom brompheniramine
carb carbinoxamine
carbeta carbetapentane
chlor chlorpheniramine
cod codeine
cypro cyproheptadine
deslorat desloratadine
dexchlo dexchlorphenirimine
dextro dextromethorphan
diphen diphenhydramine
hydrox hydroxyzine
guaiac potassium guaiacosulfonate
guaif guaifenesin
homat homatropine
hydro hydrocodone
hydrox hydroxyzine
levocetir levocetirizine
meth methscopolamine
phenyle phenylephrine
prometh promethazine
pseud pseudoephedrine
pyril pyrilamine tannate
Allerex (C) 1 AM tab in the morning and 1 PM tab in the evening prn
Pediatric: not recommended
AM tab: meth 2.5 mg/pseud 120 mg ext-rel; PM tab: meth 2.5 mg/chlor 8 mg/
phenyle 10 mg* ext-rel (Dose Pack 20: 10 AM tabs+10 PM tabs; Dose Pack 60:
30 AM tabs+30 PM tabs)
Allures-D (C) 1 tab q 12 hours prn
Pediatric: not recommended
Tab: meth 2.5 mg/pseud 120 mg ext-rel
Allerex DF (C) 1 AM tab in the morning and 1 PM tab in the evening prn
Pediatric: not recommended
AM tab: meth 2.5 mg/chlor 4 mg/PM tab: meth 2.5 mg/chlor 8 mg* (Dose Pack 20:
10 AM tabs+10 PM tabs; Dose Pack 60: 30 AM tabs+30 PM tabs)
Allerex PE (C) 1 AM tab in the morning and 1 PM tab in the evening prn
Pediatric: not recommended
AM tab: meth 2.5 mg/phenyle 40 mg/PM tab: meth 8 mg/phenyle 10 mg* (Dose Pack
20: 10 AM tabs+10 PM tabs; Dose Pack 60: 30 AM tabs+30 PM tabs)
Allerex Suspension (C) 15 ml q 12 hours prn
Pediatric: <6 years: not recommended; 6-12 years: 2.5-5 ml q 12 hours prn;
>12 years: same as adult
Susp: chlor 3 mg/phenyle 7.5 mg ext-rel (raspberry)
Atarax (B)(G) 25 mg tid or qid prn
Pediatric: <2 years: not recommended; 2-6 years: 6.25 mg q 4-6 hours prn;
6-12 years: 12.5-25 mg q 4-6 hours prn; >12 years: same as adult
Tab: hydrox 10, 25, 50, 100 mg; Syr: 10 mg/5 ml (alcohol 0.5%)
Bromfed DM (C)(G) 2 tsp q 4 hours prn: max 6 doses/day
Pediatric: <2 years: not recommended; 2-6 years: 1/2 tsp q 4 hours prn;
>6-12 years: 1
tsp q 4 hours prn; max 6 doses/day; >12 years: same as adult
Susp: brom 2 mg/pseudo 30 mg/dextro 10 mg per 5 ml (butterscotch; alcohol
0.95%)
Bromfed DM Sugar-Free (C)(G) 2 tsp q 4 hours prn: max 6 doses/day
Pediatric: <2 years: not recommended; 2-6 years: 1/2 tsp q 4 hours prn; 6-12 years: 1
tsp q 4 hours prn; >12 years: same as adult
Max 6 doses/day
Susp: brom 2 mg/pseudo 30 mg/dextro 10 mg per 5 ml (butterscotch; alcohol
0.95%)
Clarinex (C) 1 tab daily prn
Pediatric: <6 years: not recommended; =6 years: ½-1 tab once daily
Tab: deslorat 5 mg
Clarinex RediTabs (C) 5 mg daily prn
Pediatric: <6 years: not recommended; 6-12 years: 2.5 mg once daily; >12 years:
same as adult
ODT: deslorat 2.5, 5 mg (tutti-frutti; phenylalanine)
Clarinex Syrup (C) 1 tab daily prn
Pediatric: <6 months: not recommended; 6-11 months: 1 mg (2 ml) daily prn;
1-5 years: 1.25 mg (2.5 ml) daily prn; 6-11 years: 2.5 mg (5 ml) daily prn; =12 years:
5 mg (10 ml) daily prn
Tab: deslorat 0.5 mg per ml (4 oz)(tutti-frutti; phenylalanine)
Duratuss AC 12 (C) 1-2 tsp q 12 hours prn
Pediatric: <2 years: not recommended; 2-6 years: 1/2 tsp q 12 hrs prn; >6 years: 1
tsp q 12 hours prn; >6 years: same as adult
Susp:diphen 12.5 mg/dextro 15 mg/phenyle 15 mg per 5 ml (strawberry banana;
sugar-free, alcohol-free, phenylalanine)
Duratuss DM (C) 1 tsp q 4 hours prn
Pediatric: <2 years: not recommended; 2-6 years: 1/4 tsp q 4 hrs prn; >6 years: ½ tsp
q 4 hours prn
Susp: dextro 25 mg/guaif 225 mg per 5 ml (grape) (sugar-free, alcohol-free)
Duratuss DM 12 (C) 1-2 tsp q 12 hours prn; max 6 tabs/day
Pediatric: <2 years: not recommended; 2-6 years: 1/2 tsp q 12 hrs prn; >6 years:
½-1 tsp q 12 hours prn; >6 years: same as adult
Susp: dextro 15 mg/guaif 225 mg per 5 ml (grape; sugar-free, alcohol-free)
Flowtuss Oral Solution (C)(II)(G) 1-2 tsp q 4-6 hours prn; max 6 tsp/24 hours
Pediatric: <6 years: not recommended; 6-12 years: 1/2 tsp q 4-6 hours prn; max
15 ml/day; >12 years: same as adult
Oral soln: hydro 2.5 mg/guaif 200 mg per 5 ml ( black raspberry)
Comment: hydrocodone is known to be excreted in human milk.
Hycodan (C)(III) 1 tab q 4-6 hours prn; max 6 tabs/day
Pediatric: <6 years: not recommended; 6-12 years: 1/2 tab q 4-6 hours prn; max
3 tabs/day; >12 years: same as adult
Tab: hydro 5 mg/homat 1.5 mg
Comment: hydrocodone is known to be excreted in human milk.
Hycodan Syrup (C)(II)(G) 1 tsp q 4-6 hours prn
Pediatric: <6 years: not recommended; 6-12 years: 1/2 tsp q 4-6 hours prn; max
15 ml/day; >12 years: same as adult
Syr: hydro 5 mg/homat 1.5 mg per 5 ml
Comment: hydrocodone is known to be excreted in human milk.
Hycofenix Oral Solution (C)(II) 1 tsp q 4-6 hours prn
Pediatric: <6 years: not recommended; 6-12 years: 1/2 tsp q 4-6 hours prn; max
15 ml/day; >12 years: same as adult
Oral soln: hydro 2.5 mg/pseudo 30 mg/quaf 200 mg per 5 ml (black raspberry)
Comment: hydrocodone is known to be excreted in human milk.
Obredon Oral Solution (C)(II) 10 ml q 4-6 hours prn cough; max 60 ml/day
Pediatric: <18 years: not recommended
Oral soln: hydro 2.5 mg/guaif 200 mg per 5 ml
Comment: Obredon is indicated only for short term treatment of cough due to the
common cold. Obredon is not indicated for persistent or chronic cough such as
occurs with smoking, asthma, chronic bronchitis, or emphysema, or where cough
is accompanied by excessive phlegm. Use with caution in patients with diabetes,
thyroid disease, Addison’s disease, BPH or urethral stricture, and asthma. Obredon
is contraindicated with paralytic ileus, anticholinergics, TCAs, and within 14 days
of an MAOI. hydrocodone is known to be excreted in human milk. Th ere is no
FDA-approved generic form of hydrocodone/guaifenesin.
Palgic (C) 4 mg daily prn; max 24 mg/day in divided doses 6-8 hours apart
Pediatric: <2 year: not recommended; 2-3 years: 2 mg tid or qid prn or 0.2-0.4 mg/
kg/day divided tid or qid; 3-6 years: 2-4 mg daily prn or 0.2-0.4 mg/kg/day divided
tid or qid; >6 years: same as adult
Tab: carb 4*mg; Syr: carb 4 mg per 5 ml (bubble gum)
Periactin (B)(G) initially 4 mg tid prn, then adjust as needed; usual range 12-16
mg/day; max 32 mg/day
Pediatric: <2 years: not recommended; 2-6 years: 2 mg 2-3 times/day: max
12 mg daily; 7-14 years: 4 mg 2-3 times/day: max 16 mg daily; >14 years:
same as adult
Tab: cypro 4*mg; Syr: cypro 2 mg per 5 ml
Prolex-DH (C)(III) 1-1½ tsp qid prn
Pediatric: <3 years: not recommended; 3-6 years: 1/4-1/2 tsp qid prn; =6-12 years:
1/2-1 tsp qid prn; >12 years: same as adult
Liq: hydro 4.5 mg/pot guaiac 300 mg per 5 ml (tropical fruit punch; alcohol-free,
sugar-free)
Phenergan (C)(G) 25 mg po or rectally tid ac and HS prn
Pediatric: <2 years: not recommended; >2 years: 0.5 mg/lb or 6.25-25 mg po or
rectally tid; =12 years: same as adult
Tab: 12.5*, 25*, 50 mg; Syr: prom 6.25 mg per 5 ml; Syr fortis: prom 25 mg per 5 ml;
Rectal supp: prom 12.5, 25, 50 mg
Promethazine DM (C)(V)(G) 1 tsp q 4-6 hours prn
Pediatric: <6 years: not recommended; 6-12 years: ½-1 tsp q 4-6 hours prn; >12
years: same as adult
Syr: prometh 6.25 mg/dex 15 mg per 5 ml (alcohol 7%)
Comment: Contraindicated with asthma.
Promethazine VC (C)(V)(G) 1 tsp q 4-6 hours prn; max 30 ml/day
Pediatric: 2-6 years: 1.25 ml q 4-6 hours prn; max 7.5 ml/day; 6-12 years: 2.5 ml q
4-6 hours prn; max 15 ml/day; >12 years: same as adult
Syr: prometh 6.25 mg/phenyle 5 mg per 5 ml (alcohol 7%)
Comment: Contraindicated with asthma.
Promethazine VC w. Codeine (C)(V)(G) 1 tsp q 4-6 hours prn; max 30 ml/day
Pediatric: <6 years: not recommended; 6-12 years: ½-1 tsp q 4-6 hours prn; max
30 ml/day; >12 years: same as adult
Syr: prometh 6.25 mg/phenyle 5 mg/cod 10 mg per 5 ml (alcohol 7%)
Comment: Contraindicated with asthma.
Promethazine w. Codeine (C)(V)(G) 1 tsp q 4-6 hours prn
Pediatric: <6 years: not recommended; 6-12 years: ½-1 tsp q 4-6 hours prn;
>12 years: same as adult
Liq: prometh 6.25 mg/cod 10 mg per 5 ml (alcohol 7%)
Comment: Contraindicated with asthma.
Rynatan (C) 1-2 tabs q 12 hours prn
Pediatric: not recommended
Tab: chlor 9 mg/phenyle 25 mg
Rynatan Pediatric Suspension (C)
Pediatric: <2 years: not recommended; 2-6 years: ½-1 tsp q 12 hours prn;
>6-12 years: 1-2 tsp q 12 hours prn; >12 years: same as adult
Susp: chlor 4.5 mg/phenyle 5 mg
Ryneze (C) 1 tab q 12 hours prn
Pediatric: <6 years: not recommended; 6-12 years: 1/2 tab q 12 hours prn; >12 years:
same as adult
Tab: chlor 8 mg/meth 2.5 mg
Robitussin AC (C)(III)(G) 2 tsp q 4 hours prn; max 60 ml/day
Pediatric: <2 years: not recommended; 2-6 years: 1/4-1/2 tsp q 4 hours prn;
6-12 years: 1 tsp q 4 hours prn; >12 years: same as adult
Liq: cod 10 mg/guaif 100 mg per 5 ml
Rondec Syrup (C)(G) 1 tsp qid prn; max 30 ml/day
Pediatric: <2 years: not recommended; 2-5 years: 1/4 tsp q 4-6 hours prn; max
7.5 ml/day; 6-11 years: 1/2 tsp q 4-6 hours prn; max 15 ml/day; >11 years: same
as adult
Syr: phenyle 12.5 mg/chlor 4 mg per 5 ml (bubblegum; sugar-free, alcohol-free)
Semprex-D (B) 1 cap q 4-6 hours prn; max 4 doses/day
Pediatric: not recommended
Cap: acriv 8 mg/pseud 60 mg
Tanafed DMX (C)(G) 2-4 tsp q 12 hours prn
Pediatric: <2 years: not recommended; 2-6 years: ½-1 tsp q 12 hours prn;
6-12 years: 1-2 tsp q 12 hours prn
Susp: dexchlor 2.5 mg/pseud 75 mg/dextro 25 mg per 5 ml (cotton candy,
alcohol-free)
Tessalon Caps (C) 100-200 mg tid prn; max 600 mg/day
Pediatric: <10 years: not recommended; =10 years: same as adult
Cap: benzo 200 mg
Comment: Swallow whole. Do not suck or chew.
Tessalon Perles (C) 100-200 mg tid prn; max 600 mg/day
Pediatric: <10 years: not recommended; =10 years: same as adult
Perles: benzo 100 mg
Comment: Swallow whole. Do not suck or chew.
Tussi-12 D Tablets (C) 1-2 tabs q 12 hours prn
Pediatric: <6 years: use susp; 6-11 years: ½-1 tab q 12 hours prn; >11 years: same
as adult
Tab: carbeta 60 mg/pyril 40 mg/phenyle 10*mg
Tussi-12 D S (C) 1-2 tsp q 12 hours prn
Pediatric: <2 years: individualize; 2-6 years: ½-1 tsp q 12 hours prn; 6-12 years:
1-2 tsp q 12 hours prn; >12 years: same as adult
Liq: carbeta 30 mg/pyril 30 mg/phenyle 5 mg per 5 ml (strawberry-currant;
tartrazine)
TussiCaps 5 mg/4 mg (C)(III) 2 caps q 12 hours prn; max 4 caps/day
Pediatric: <6 years: not recommended; 6-11 years: 1 cap q 12 hours prn; max 2 caps/
day; >11 years: same as adult
Cap: hydro 5 mg/chlor 4 mg ext-rel (alcohol)
TussiCaps 10 mg/8 mg (C)(III) 1 cap q 12 hours prn; max 2 caps/day
Pediatric: not recommended
Cap: hydro 10 mg/chlor 8 mg ext-rel (alcohol)
Tussionex (C)(III) 1 tsp q 12 hours prn
Pediatric: <6 years: not recommended; >6 years: same as adult; 6-12 years: ½ tsp
q 12 hours prn; >12 years: same as adult
Susp: hydro 10 mg/chlor 8 mg per 5 ml ext-rel
Tussi-Organidin DM NR Liquid (C)(III) 5 ml q 4 hours prn; max 40 ml/day
Pediatric: <6 months: not recommended; 6-23 months: 0.6 ml q 4 hours prn; max
3.7 ml/day; 2-5 years: 1.25 ml q 4 hours prn; max 7.5 ml/day; 6-11 years: 2.5 ml
q 4 hours prn; max 15 ml/day; =12 years: same as adult
Liq: dextro 10 mg/guaif 300 mg per 5 ml (grape; sugar-free, alcohol-free)
Tussi-Organidin NR (C)(V) 1 tsp q 4 hours prn; max 40 ml/day
Pediatric: <2 years: not recommended; 2 years: 1.5 ml q 4-6 hours prn; max 6 ml/
day; 3 years: 1.75 ml q 4-6 hours prn; max 7 ml/day; 4 years: 2 ml q 4-6 hours prn;
max 8 ml/day; 5 years: 2.25 ml q 4-6 hours prn; max 9 ml/day; 6-11 years: 2.5 ml
q 4 hours prn; max 20 ml/day; =12 years: same as adult
Liq: cod 10 mg/guaif 300 mg per 5 ml (grape; sugar-free, alcohol-free)
Tuzistra XR (C)(III) 1-2 tsp q 12 hours prn; max 20 ml/day
Pediatric: <18 years: not recommended
Liq: cod 14.7 mg/chlor 2.8 mg per 5 ml (cherry)
Vistaril (C)(G) 25 mg tid or qid prn
Pediatric: <6 years: 50 mg/day prn; 6-12 years: 50-100 mg daily prn; >12 years: same
as adult
Cap: hydrox 25, 50, 100 mg; Susp: hydrox 25 mg/5 ml (lemon)
Xyzal, Xyzal Oral Solution (B) 2.5-5 mg in the evening prn
CrCl 30-50 mL/min: 2.5 mg every other day
CrCl 10-30 mL/min: 2.5 mg twice weekly
CrCl <10 mL/min or hemodialysis: contraindicated
Pediatric: <6 months: not recommended; 6 months to 5 years: max 1.25 mg once
daily in the PM prn; 6-11 years: max 2.5 mg once daily in the PM prn; =12 years:
same as adult
Tab: levocetir 5*mg fi lm-coat; Oral soln: levocetir 0.5 mg/ml (150 ml)
APPENDIX BB: SYSTEMIC
ANTI- INFECTIVE DRUGS
Comment:
• Adverse eff ects of aminoglycosides include nephrotoxicity and ototoxicity.
• Use cephalosporins with caution in persons with penicillin allergy due to potential
cross allergy.
• Sulfonamides are contraindicated with sulfa allergy and G6PD defi ciency. A high
fl uid intake is indicated during sulfonamide therapy.
• Tetracyclines should be taken on an empty stomach to facilitate absorption. Tetracyclines
should not be taken with milk.
• Tetracyclines are contraindicated during pregnancy and breastfeeding, and in children
<8 years of age, due to the risk of developing tooth enamel discoloration.
• Systemic quinolones and fl uoroquinolones are contraindicated in pregnancy and
children <18 years of age due to the risk of joint dysplasia.
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
Amebicide
chloroquine
phosphate (C)
Aralen Tab: 500 mg; Inj: 50 mg/ml (5 ml)
iodoquinol (C) Yodoxin Tab: 210, 650 mg
metronidazole (not
for use in 1st; B in
2nd, 3rd)(G)
Flagyl Tab: 250*, 500* mg
Flagyl 375 Cap: 375 mg
Flagyl ER Tab: 750 mg ext-rel
tinidazole (C) Tindamax Tab: 250*, 500* mg
Antihelmintic
albendazole (C)(G) Albenza Tab: 200 mg
mebendazole (C)(G) Emverm, Vermox Chew tab: 100 mg
Pin-X Cap: 180 mg; Liq: 50 mg/ml (30 ml);
144 mg/ml (30 ml); Oral susp: 50 mg/
ml (30 ml)
Antifungal
atovaquone (C) Mepron Susp: 750 mg/5ml (210 ml)
clotrimazole (B)(G) Mycelex Troche 10 mg (70, 40/bottle)
fl uconazole (C)(G) Difl ucan Tab: 50, 100, 150, 200 mg; Oral susp:
10, 40 mg/ml (35 ml) (orange)
griseofulvin,
microsize (C)
Grifulvin V Tab: 250, 500 mg; Oral susp: 125 mg/
5 ml (120 ml) (alcohol 0.02%)
Gris-PEG Tab: 125, 250 mg
itraconazole (C) Sporanox Cap: 100 mg; Soln: 10 mg/ml (150 ml);
Pulse Pack: 100 mg caps (7/pck)
ketoconazole (C)(G) Nizoral Tab: 200 mg
nystatin (C)(G) Mycostatin Pastille: 200,000 units/pastille (30
pastilles/pck); Oral susp: 100,000
units/ml (60 ml w. dropper)
terbinafi ne (B)(G) Lamisil Tab: 250 mg
vorconazole (D)(G) Vfend Tab: 50, 200 mg
Antimalarial
atovaquone/
proguanil (C)
Malarone Tab: atov 250 mg/proq 100 mg
Malarone Pediatric Tab: atov 62.5 mg/proq 25 mg
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
chloroquine (C)(G) Aralen Tab: 500 mg; Amp: 50 mg/ml (5 ml)
doxycycline (D)(G) Actilate Tab: 75, 150**mg
Adoxa Tab: 50, 75, 100, 150 mg ent-coat
Doryx Cap: 100 mg;
Tab: 50, 75, 100, 150, 200 mg
Monodox Cap: 50, 75, 100 mg
Oracea Cap: 40 mg del-rel
Vibramycin Cap: 50, 100 mg; Syr: 50 mg/5 ml
(raspberry-apple) (sulfi tes); Oral susp:
25 mg/5 ml (raspberry)
Vibra-Tab Tab: 100 mg fi lm-coat
hydroxychloroquine
(C)(G)
Plaquenil Tab: 200 mg
mefl oquine (C) Lariam Tab: 250 mg
Antiprotozoal/Antibacterial
metronidazole (not
for use in 1st; B in
2nd, 3rd)(G)
Flagyl, Protostat Tab: 250*, 500* mg
Flagyl 375 Cap: 375 mg
Flagyl ER Tab: 750 mg ext-rel
tinidazole (C) Tindamax Tab: 250*, 500*mg
Antiviral (for HIV-specifi c antiviral drugs see page 523)
acyclovir (C)(G) Zovirax Cap: 200 mg; Tab: 400, 800 mg; Oral
susp: 200 mg/5 ml (banana)
amantadine (C)(G) Symmetrel Tab: 100 mg; Syr: 50 mg/5ml (16 oz)
(raspberry)
famciclovir (B) Famvir Tab: 125, 250, 500 mg
lamivudine (C) Epivir-HBV Tab: 100 mg; Oral soln: 5 mg/ml (240
ml) (strawberry-banana)
oseltamivir (C) Tamifl u Cap: 75 mg
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
rimantadine (C) Flumadine Tab: 100 mg
valacyclovir (B) Valtrex Tab: 500 mg; 1 g
zanamivir Relenza Tab: lami 150/zido 300 mg
Antitubercular
ethambutol (EMB)
(B)(G)
Myambutol Tab: 100, 400*mg
isoniazid (INH)
(C)(G)
generic only Tab: 100, 300*mg; Syr: 50 mg/5 ml; Inj:
100 mg/ml
pyrazinamide
(PZA) (C)
generic only Tab: 500*mg
rifampin (C)(G) Prift in Tab: 150 mg
Rifadin Cap: 150, 300 mg
rifampin/isoniazid
(C)
Rifamate Cap: rif 300 mg/iso 150 mg
rifampin/isoniazid/
pyrazinamide (C)
Rifater Tab: rif 120 mg/iso 50 mg/pyr 300 mg
Aminoglycoside
amikacin (C) Amikin Vial: 500 mg, 1 g (2 ml)
gentamicin (C)(G) Garamycin Vial: 20, 80 mg/2 ml
streptomycin (D)(G) Streptomycin Amp: 1 g/2.5 ml or 400 mg/ml (2.5 ml)
Cephalosporin
First Generation Cephalosporin
cefadroxil (B) Duricef Cap: 500 mg; Tab: 1 g; Oral susp:250
mg/5 ml (100 ml); 500 mg/5 ml (75,
100 ml) (orange-pineapple)
cefazolin (B) Ancef, Zolicef Vial: 500 mg; 1, 10 g
cephalexin (B) Kefl ex Cap: 250, 333, 500, 750 mg;
Oral susp:125, 250 mg/5 ml (100,
200 ml)
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
Second Generation Cephalosporin
cefaclor (B)(G) generic only Tab: 500 mg; Cap: 250, 500 mg;
Susp: 125 mg/5 ml (75, 150 ml)
(strawberry); 187 mg/5 ml (50, 100
ml) (strawberry); 250 mg/5 ml (75,
150 ml) (strawberry); 375 mg/5 ml
(50, 100 ml) (strawberry)
Cefaclor Extended
Release
Tab: 375, 500 mg ext-rel
cefamandole (B) Mandol Vial: 1, 2 g
cefotetan (B) Cefotan Vial: 1, 2 g
cefoxitin (B) Mefoxin Vial: 1, 2 g
cefprozil (B) Cefzil Tab: 250, 500 mg; Oral susp: 125,
250 mg/5 ml (50, 75, 100 ml) (bubble
gum) (phenylalanine)
ceft aroline (B) Tefl aro Vial: 400, 600 mg
cefuroxime axetil
(B)
Ceft in Tab: 250, 500 mg; Oral susp: 125, 250
mg/5 ml (50, 100 ml) (tutti-frutti)
cefuroxime sodium
(B)(G)
Zinacef Vial: 750 mg; 1.5 g
loracarbef (B) Lorabid Pulvule: 200, 400 mg; Oral susp: 100
mg/5 ml (50, 100 ml); 200 mg/5 ml (50,
75, 100 ml) (strawberry bubble gum)
Th ird Generation Cephalosporin
cefoperazone (B) Cefobid Vial: 1, 2 g pwdr for reconstitution
cefotaxime (B) Claforan Vial: 500 mg; 1, 2 g pwdr for
reconstitution
cefpodoxime (B) Vantin Tab: 100, 200 mg; Oral susp: 50, 100
mg/5 ml (50, 75, 100 ml) (lemon creme)
ceft azidime (B) Ceptaz Vial: 1, 2 g pwdr for reconstitution
Fortaz Vial: 500 mg; 1, 2 g pwdr for
reconstitution
Tazicef Vial: 1, 2 g pwdr for reconstitution
Tazidime Vial: 1, 2 g pwdr for reconstitution
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
ceft azidime/
avibactam (B)
Avycaz Vial: 2.5 g pwdr for reconstitution
ceft ibuten (B) Cedax Cap: 400 mg; Oral susp: 90 mg/5 ml
(30, 60, 90, 120 ml); 180 mg/5 ml (30,
60, 120 ml) (cherry)
Th ird/Fourth Generation Cephalosporin
cefdinir (B) Omnicef Cap: 300 mg; Oral susp: 125 mg/5 ml
(60, 100 ml) (strawberry)
cefditoren pivoxil (C) Spectracef Tab: 200 mg
cefepime (B) Maxipime Vial: 1 g pwdr for reconstitution
cefi xime (B) Suprax Tab/Cap: 400 mg; Oral Susp: 100 mg/
5 ml (50, 75, 100 ml)(strawberry)
ceft aroline (B) Tefl aro Vial: 400, 600 mg
ceft riaxone (B)(G) Rocephin Vial: 250, 500 mg; 1, 2 g
cytolozane/
tazobactam (B)
Zerbaxa Vial: 1.5 g pwdr for reconstitution
Fluoroquinolone and Quinolone
First-Generation Quinolone
enoxacin (C) Penetrex Tab: 200, 400 mg
Second-Generation Fluoroquinolone
ciprofl oxacin (C)
(G)
Cipro Tab: 250, 500, 750 mg; Oral susp: 250,
500 mg/5 ml (100 ml) (strawberry)
IV conc: 10 mg/ml aft er dilution (20,
40 ml); IV premix: 2 mg/ml (100,
200 ml)
Cipro XR Tab: 500, 1000 mg ext-rel
ProQuin XR Tab: 500 mg ext-rel
lomefl oxacin (C) Maxaquin Tab: 400 mg
norfl oxacin (C)(G) Noroxin Tab: 400 mg
ofl oxacin (C)(G) Floxin Tab: 200, 300, 400 mg
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
Th ird-Generation Fluoroquinolone
levofl oxacin (C)(G) Levaquin Tab: 250, 500, 750 mg
Fourth-Generation Fluoroquinolone
gemifl oxacin (C)(G) Factive Tab: 320*mg
moxifl oxacin (C)
(G)
Avelox Tab: 400 mg
Ketolide
telithromycin (C) Ketek Tab: 300, 400 mg
Macrolide
azithromycin (B) Zithromax Tab: 250, 500, 600 mg; Pkt: 1 g for
reconstitution (cherry-banana)
ZithPed Syr Oral susp: 100 mg/5 ml, (15 ml); 200
mg/5 ml (15, 22.5, 30 ml) (cherry)
Zithromax Tri-Pak Tab: 3 x 500 mg tabs/pck
Zithromax Z-Pak Tab: 6 x 250 mg tabs/pck
Zmax Pkt: 2 g for reconstitution (cherrybanana)
clarithromycin
(C)(G)
Biaxin Tab: 250, 500 mg; Oral susp: 125,
250 mg/5 ml (50, 100 ml)(fruit punch)
Biaxin XL Tab: 500 mg ext-rel
dirithromycin (C)(G) generic only Tab: 250 mg
erythromycin base
(B)(G)
Ery-Tab Tab: 250, 333, 500 mg ent-coat
PCE Tab: 333, 500 mg
erythromycin
estolate (B)(G)
Ilosone Pulvule: 250 mg; Tab: 500 mg; Liq: 125,
250 mg/5 ml (100 ml)
erythromycin
ethylsuccinate
(B)(G)
E.E.S. Tab: 400 mg; Oral susp: 200 mg/5 ml
(100, 200 ml) (cherry); 200,
400 mg/5 ml (100 ml)(fruit)
EryPed Oral susp: 200 mg/5 ml (100, 200 ml)
(fruit); 400 mg/5 ml (60, 100, 200 ml)
(banana); Oral drops: 200, 400 mg/5 ml
(50 ml) (fruit); Chew tab: 200 mg
wafer (fruit)
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
erythromycin
stearate (B)(G)
Erythrocin Film tab: 250, 500 mg
Penicillin
amoxicillin (B)(G) Amoxil Cap: 250, 500 mg; Tab: 500, 875* mg;
Chew tab: 125, 200, 250, 400 mg
(cherry-banana-peppermint)
(phenylalanine); Oral susp:125, 250
mg/ml (80, 100, 150 ml) (bubble
gum); 200, 400 mg/5ml (50, 75, 100
ml) (bubble gum); Oral drops: 50 mg/
ml (30 ml) (bubble gum)
Moxatag Tab: 775 mg ext-rel
Trimox Cap: 250, 500 mg; Oral susp: 125, 250
mg/5ml (80, 100, 150 ml) (raspberrystrawberry)
amoxicillin/
clavulanate (B)(G)
Augmentin Tab: 250, 500, 875 mg; Chew tab: 125,
250 mg (lemon lime); 200, 400 mg
(cherry-banana; phenylalanine); Oral
susp: 125 mg/5 ml (banana), 250 mg/
5 ml (orange) (75, 100, 150 ml); 200,
400 mg/5ml (50, 75, 100 ml) (orange)
Augmentin ES-600 Oral susp: 600 mg/5 ml (50, 75, 100,
125, 150, 200 ml) (strawberry cream)
(phenylalanine)
Augmentin XR Tab: 1000*mg ext-rel
ampicillin (B)(G) Omnipen Cap: 250, 500 mg; Oral susp: 125, 250
mg/ml (100, 150, 200 ml)
Principen Cap: 250, 500 mg; Syr: 125, 250 mg/5
ml
ampicillin/
sulbactam (B)(G)
Unasyn Vial: 1.5, 3 g
carbenicillin (B) Geocillin Tab: 382 mg fi lm-coat
dicloxacillin (B)(G) Dynapen Cap: 125, 250, 500 mg; Oral susp: 62.5
mg/5 ml (80, 100, 200 ml)
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
ertapenem (B) Ivanz Vial: 1 g pwdr for reconstitution
meropenem (B)(G) Merrem Vial: 500 mg; 1 g pwdr for
reconstitution (sodium 3.92 mEq/g)
penicillin G
benzathine (B)(G)
Bicillin LA,
Bicillin C-R
Cartridge-needle unit: 600,000 million
units (1 ml); 1.2 million units (2 ml);
2.4 million units (4 ml)
Permapen Prefi lled syringe: 1.2 million units
penicillin G
procaine (B)(G)
generic only Prefi lled syringe: 1.2 million units
penicillin v
potassium (B)(G)
Pen-Vee K Tab: 250, 500 mg; Oral soln: 125 mg/5
ml (100, 200 ml); 250 mg/5 ml (100,
150, 200 ml)
piperacillin/
tazobactam (B)(G)
Zosyn Vial: 2, 3, 4 g pwdr for reconstitution
Sulfonamide
sulfamethoxazole
(B/D)(G)
Gantrisin Pediatric Oral susp: 500 mg/5 ml; Syr: 500 mg/5
ml
trimethoprim (C)
(G)
Primsol Oral soln: 50 mg/5 ml (bubble gum)
(dye-free, alcohol-free)
Trimpex Tab: 100 mg
Proloprim Tab: 100, 200 mg
trimethoprim/
sulfamethoxazole
(C)(G)
Bactrim, Septra Tab: trim 80 mg/sulfa 400 mg*
Bactrim DS,
Septra DS
Tab: trim 160 mg/sulfa 800 mg*; Oral
susp: trim 40 mg/sulfa 200 mg per 5 ml
(100 ml) (cherry) (alcohol 0.3%)
Tetracycline
demeclocycline (D) Declomycin Tab: 300 mg
doxycycline (D)(G) Adoxa Tab: 50, 100 mg ent-coat
Doryx Cap: 100 mg
Monodox Cap: 50, 100 mg
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
doxycycline (D)(G) Vibramycin Cap: 50, 100 mg; Syr: 50 mg/5 ml;
(raspberry) (sulfi tes); Oral susp: 25 mg/5
ml (raspberry-apple); IV conc: doxy 100
mg/asc acid 480 mg aft er dilution; doxy
200 mg/asc acid 960 mg aft er dilution
Vibra-Tab Tab: 100 mg fi lm-coat
minocycline (D)(G) Dynacin Cap: 50, 100 mg
Minocin Cap: 50, 100 mg; Oral susp: 50 mg/5
ml (60 ml) (custard) (sulfi tes, alcohol
5%); Vial: 100 mg soln for inj:
tetracycline (D)(G) Achromycin V Cap: 250, 500 mg
Sumycin Tab: 250, 500 mg; Oral susp: 125 mg/5
ml (fruit) (sulfi tes)
Macrolide/Sulfi soxazole
erythromycin
ethylsuccinate/
sulfi soxazole (C)(G)
Pediazole Oral susp: eryth 200 mg/sulf 600
mg per 5 ml (100, 150, 200 ml)
(strawberry-banana)
Miscellaneous
aztreonam (B) Cayston Vial: 75 mg pwdr for reconstitution
(preservative-free)
chloramphenicol
(C)(G)
Chloromycetin Vial: 1 g
clindamycin (B)(G) Cleocin Cap: 75 (tartrazine), 150 (tartrazine),
300 mg; Oral susp: 75 mg/5 ml (100
ml) (cherry); Vial: 150 mg/l (2, 4 ml)
(benzyl alcohol)
dalbavancin (C) Dalvance Vial: 500 mg pwdr for IV infusion
(preservative-free)
daptomycin (B)(G) Cubicin Vial: 500 mg pwdr for reconstitution
doripenem (B) Doribax Vial: 500 mg pwdr for reconstitution
fosfomycin (B) Monurol Sachet: 3 g single-dose (mandarin
orange; sucrose)
Anti-infectives by Class With Dose Forms
Generic Name Brand Name Dose Form/Volume
imipenem/cilastatin
(C)(G)
Primaxin Vial: imip 500 mg/cila 500 mg;
imip 750 mg/cila 750 mg pwdr for
reconstitution
lincomycin (B)(G) Lincocin Vial: 300 mg/ml (10 ml)
linezolid (C)(G) Zyvox Tab: 400, 600 mg; Oral susp: 100 mg/5
ml (orange) (phenylalanine); IV: 2 mg
ml (100, 200, 300 ml)
meropenem (B) Merrem Vial: 500 mg; 1 g (sodium 3.92 mEq/g)
nitrofurantoin (B)
(G)
Furadantin Oral susp: 25 mg/5 ml (60 ml)
Macrobid Cap: 100 mg
Macrodantin Cap: 25, 50, 100 mg
quinupristin/
dalfopristin (B)
Synercid Vial: 150 mg/350 mg, 180 mg/420 mg
tygecycline (D)(G) Tygacil Vial: 50 mg pwdr for reconstitution
rifaximin (C) Xifaxan Tab: 200, 550 mg
telavancin (C) Vibativ Vial: 250, 750 mg pwdr for
reconstitution for IV infusion
(preservative-free)
vancomycin (C)(G) Vancocin Cap: 125, 250 mg; Vial: 500 mg, 1 g
pwdr for reconstitution for IV infusion
APPENDIX CC.1: ACYCLOVIR (ZOVIRAX SUSPENSION )
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/5-Day Volume (ml)
20 mg/kg/d
ml/dose qid 3.5 4.5 5.5 6.5 8 9 10 11.5 12.5 13.5 14.5 16
mg/5ml 200 200 200 200 200 200 200 200 200 200 200 200
Volume (ml) 70 90 110 130 160 180 200 230 250 270 290 320
Zovirax Oral Suspension <2 years: not recommended; >2 years, <40 kg: 20 mg/kg dosed qid x 5 days; =2 years, >40 kg: 800 mg dosed
qid x 5 days; Oral susp: 200 mg/5 ml (banana).
APPENDIX CC.2: AMANTADINE (SYMMETREL SYRUP)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
4 mg/kg/d
ml/dose bid 3 4 5 6 7 8 9 10 11 12 13 14
mg/5ml 50 50 50 50 50 50 50 50 50 50 50 50
Volume (ml) 30 40 50 60 70 80 90 100 110 120 130 140
8 mg/lb/d
ml/dose bid 6 8 10 12
mg/5ml 50 50 50 50
Volume (ml) 60 80 100 60
Symmetrel Suspension (C)(G) Symmetrel <1 year: not recommended; 1-8 years: max 150 mg/day; 9-12 years: 2 tsp bid; >12 years:
100 mg bid or 200 mg once daily; Syr: 50 mg/5 ml (raspberry).
APPENDIX CC.3: AMOXICILLIN (AMOXIL SUSPENSION, TRIMOX SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
20 mg/kg/d
ml/dose tid 2 2.5 3 3.5 4 5 5.5 6 7 7.5 8 9
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 60 75 90 105 120 150 165 180 210 225 240 270
30 mg/kg/d
ml/dose tid 3 3.5 2.5 3 3 3.5 4 4.5 5 5.5 6 6.5
mg/5ml 125 125 250 250 250 250 250 250 250 250 250 250
Volume (ml) 90 105 75 90 90 105 120 135 150 165 180 195
40 mg/kg/d
ml/dose bid 5 7 4.5 5 6 7 8 9 10 11 12 13
mg/5ml 125 125 250 250 250 250 250 250 250 250 250 250
Volume (ml) 100 140 90 100 120 140 160 180 200 220 240 250
45 mg/kg/d
ml/dose bid 4 2.5 3 4 4.5 5 6 6.5 7 7.5 8.5 9
mg/5ml 200 400 400 400 400 400 400 400 400 400 400 400
Volume (ml) 80 50 60 80 90 100 120 130 140 150 170 180
90 mg/kg/d
ml/dose bid 8 5 6 7 9 10 12 13 14 15 17 18
mg/5ml 200 400 400 400 400 400 400 400 400 400 400 400
Volume (ml) 160 100 120 140 180 200 240 260 280 300 340 360
<40 kg (88 lb): 20-30 mg/kg/day in 3 divided doses or 40-90 mg/kg/day in 2 divided doses; >40 kg: same as adult.
Amoxil Suspension (B)(G) 125, 250 mg/5ml (80, 100, 150 ml) (strawberry); 200, 400 mg/5 ml (50, 75, 100 ml) (bubble gum).
Trimox Suspension (B)(G) 125, 250 mg/5 ml (80, 100, 150 ml) (raspberry-strawberry).
APPENDIX CC.3: AMOXICILLIN (AMOXIL SUSPENSION, TRIMOX SUSPENSION)
APPENDIX CC.4: AMOXICILLIN/CLAVULANATE (AUGMENTIN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
40 mg/kg/d
ml/dose bid 5.5 7 4.5 5.5 6.5 7 8 9 10 11 12 13
mg/5ml 125 125 250 250 250 250 250 250 250 250 250 250
Volume (ml) 110 140 90 110 130 140 160 180 200 220 240 260
45 mg/kg/d
ml/dose bid 3 4 5 6 7 8 9 10 11.5 12.5 13.5 14.5
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 60 80 100 120 140 160 180 200 230 250 270 290
45 mg/kg/d
ml/dose bid 4 2.5 3 4 4.5 5 6 6.5 7 7.5 8.5 9
mg/5ml 200 400 400 400 400 400 400 400 400 400 400 400
Volume (ml) 80 50 60 80 90 100 120 130 140 150 170 180
90 mg/kg/d
ml/dose bid 4 5 6.5 8 9 10 11.5 13 14 15.5 16.5 18
mg/5ml 400 400 400 400 400 400 400 400 400 400 400 400
Volume (ml) 80 100 130 160 180 200 240 260 280 300 340 360
Augmentin Suspension (B)(G) 40-45 mg/kg/day divided tid or 90 mg/kg/day divided bid; 125mg/5 ml (75, 100, 150 ml) (banana), 250
mg/5 ml (75, 100, 150 ml) (orange); 200, 400 mg/5 ml (50, 75, 100 ml) (orange-raspberry) (phenylalanine).
APPENDIX CC.5: AMOXICILLIN/CLAVULANATE (AUGMENTIN ES 600 SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
40 mg/kg/d
ml/dose bid 1 1.5 2 2 2.5 3 3.5 4 4 4.5 5 5
mg/5ml 600 600 600 600 600 600 600 600 600 600 600 600
Volume (ml) 30 40 40 40 50 60 70 80 80 90 100 100
45 mg/kg/d
ml/dose bid 1.25 1.5 2 2.5 3 3.5 4 4.5 5 5 5.5 6
mg/5ml 600 600 600 600 600 600 600 600 600 600 600 600
Volume (ml) 25 30 40 50 60 70 80 90 100 100 110 120
90 mg/kg/d
ml/dose bid 2.5 3.5 4 5 6 7 8 8.5 9.5 10 11 12
mg/5ml 600 600 600 600 600 600 600 600 600 600 600 600
Volume (ml) 50 70 80 100 120 140 160 170 190 200 220 240
Augmentin ES 600 Suspension (B) <3 months: not recommended; =3 months, <40 kg: 90 mg/kg/day in 2 divided doses; =40 kg: not
recommended; 600 mg/5 ml (50, 75, 100, 125, 150, 200 ml) (strawberry cream) (phenylalanine).
APPENDIX CC.6: AMPICILLIN (OMNIPEN SUSPENSION, PRINCIPEN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
50 mg/kg/d
ml/dose q6h 3.5 4.5 3 3.5 4 4.5
mg/5ml 125 125 250 250 250 250
Volume (ml) 140 180 120 140 160 180
100 mg/kg/d
ml/dose q6h 3.5 4.5 6 7 8 9
mg/5ml 250 250 250 250 250 250
Volume (ml) 140 180 240 280 320 360
Omnipen Suspension, Principen Suspension (B)(G) >20 kg: 250-500 mg q 6 h 125, 250 mg/5 ml (100, 150, 200 ml) (fruit).
Weight
Pounds 11 22 33 44 55 66 77 88
Kilograms 5 10 15 20 25 30 35 40
Single Dose (ml)/Frequency/Strength/Volume (ml)
3 Day Regimen
10 mg/kg qd 2.5 5 7.5 5 6 7.5 9 10
mg/5ml 100 100 100 200 200 200 200 200
Volume (ml) 7.5 15 22.5 15 18 22.5 27 30
5 Day Regimen
10 mg/kg qd
Day 1 2.5 5 7.5 5 6 7.5 7.5 10
Days 2–5 1.25 2.5 4 2.5 3 4 4 5
mg/5ml 100 100 100 200 200 200 200 200
Volume (ml) 10 15 23.5 15 18 23.5 23.5 30
Zithromax ES 600 Suspension (B)(G) 100 mg/5 ml (15 ml), 200 mg/5 ml (15, 22.5, 30 ml) (cherry-vanilla-banana).
APPENDIX CC.8: CEFACLOR (CECLOR SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
20 mg/kg/d
ml/dose tid 2 2.5 3 3.5 4 5 5.5 6 7 7.5 8 8.5
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 60 75 90 105 120 150 165 180 210 225 240 255
20 mg/kg/d
ml/dose tid 1.5 1.5 2 2.5 3 3 4 4 4.5 5 5.5 6
mg/5ml 187 187 187 187 187 187 187 187 187 187 187 187
Volume (ml) 45 45 60 75 90 90 105 120 135 150 165 180
40 mg/kg/d
ml/dose tid 2 2.5 3 3.5 4 5 5.5 6 6.5 7 8 8.5
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 60 75 90 105 120 150 165 180 195 210 240 255
40 mg/kg/d
ml/dose tid 1.5 1.5 2 2.5 3 3 3.5 4 4.5 5 5 5.5
mg/5ml 375 375 375 375 375 375 375 375 375 375 375 375
Volume (ml) 45 45 60 75 90 90 105 120 135 150 150 165
Ceclor Suspension (B) <6 months: not recommended; 125, 250 mg/5 ml (75, 150 ml) (strawberry); 187, 375 mg/5ml (50, 100 ml)
(strawberry).
APPENDIX CC.9: CEFADROXIL (DURICEF SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
30 mg/kg/d
ml/dose bid 2 3 3.5 4 5 5.5 6 7 7.5 8 9 9.5
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 40 60 75 80 100 110 120 140 150 160 180 190
30 mg/kg/d
ml/dose qd 2 3 3.5 4 5 5.5 6 7 7.5 8 9 9.5
mg/5ml 500 500 500 500 500 500 500 500 500 500 500 500
Volume (ml) 20 30 35 40 50 55 60 70 75 80 90 95
Duricef Suspension (B) 250 mg/5 ml (100 ml) (orange-pineapple); 500 mg/5ml (75, 100 ml) (orange-pineapple).
APPENDIX CC.10: CEFDINIR (OMNICEF SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
7 mg/kg/d
ml/dose bid 2 2.5 3 4 4.5 5 6 6.5 7 7.5 8 9
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 40 50 60 80 90 100 120 130 140 150 160 180
14 mg/kg
ml/dose bid 4 5 6 8 9 10 12 13 14 15 16 18
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 40 50 60 80 90 100 120 130 140 150 160 180
Omnicef Suspension (B) <6 months: not recommended; 125 mg/5 ml (60, 100 ml) (strawberry).
APPENDIX CC.11: CEFIXIME (SUPRAX ORAL SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
8 mg/kg/d
ml/dose bid 1.3 1.8 2.2 2.5 3.1 3.5 4 4.5 5 5.5 6 6.5
mg/5ml 100 100 100 100 100 100 100 100 100 100 100 100
8 mg/kg/d
ml/dose qd 2.7 3.6 4.5 5.5 6.3 7.2 8.2 9 10 11 12 13
mg/5ml 100 100 100 100 100 100 100 100 100 100 100 100
Volume (ml) 27 36 45 55 65 70 80 90 100 110 120 130
Supra Oral Suspension (B)(G) <6 months: not recommended; 100 mg/5 ml (50, 75, 100 ml) (strawberry).
APPENDIX CC.12: CEFPODOXIME PROXETIL (VANTIN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
5 mg/kg/d
ml/dose bid 3.5 4.5 5.5 7 8 9 10 11 12.5 13.5 15 16
mg/5ml 50 50 50 50 50 50 50 50 50 50 50 50
Volume (ml) 70 90 110 140 160 180 200 220 250 270 300 320
5 mg/kg/d
ml/dose bid 2 2 3 3.5 4 4.5 5 5.5 6 7 7.5 8
mg/5ml 100 100 100 100 100 100 100 100 100 100 100 100
Volume (ml) 40 40 60 70 80 90 100 110 120 140 150 160
Vantin Suspension (B) <2 months: not recommended; 50, 100 mg/5 ml (50, 75, 100 ml) (lemon-crème).
APPENDIX CC.13: CEFPROZIL (CEFZIL SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
7.5 mg/kg/d
ml/dose bid 2 3 3.5 4 5 5.5 6 7 7.5 4 4.5 5
mg/5ml 125 125 125 125 125 125 125 125 125 250 250 250
Volume (ml) 40 60 70 80 100 110 120 140 150 80 90 100
15 mg/kg/d
ml/dose bid 2 3 3.5 4 5 5 6 7 7.5 8 9 9.5
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 40 60 70 80 100 100 120 140 150 160 180 190
20 mg/kg/d
ml/dose qd 3 3.5 4.5 5.5 6.5 7 8 9 10 11 12 13
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 60 70 90 110 130 140 160 180 200 220 240 260
Cefzil Suspension (B) =6 months: not recommended; 2-12 years: 7.5-20 mg/kg bid >12 years: same as adult, 250-500 mg bid or 500 mg
once daily; 125, 250 mg/5 ml (50, 75, 100 ml) (bubble gum) (phenylalanine).
APPENDIX CC.14: CEFTIBUTEN (CEDAX SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
9 mg/kg/d
ml/dose qd 3.5 4.5 6 7 8 9 10 11.5 12.5 13.5 15 16
mg/5ml 90 90 90 90 90 90 90 90 90 90 90 90
Volume (ml) 35 45 60 70 80 90 100 115 125 135 150 160
9 mg/kg/d
ml/dose qd 1.75 2.3 3 3.5 4 4.5 5 5.4 6.2 6.6 7.5 8
mg/5ml 180 180 180 180 180 180 180 180 180 180 180 180
Volume (ml) 20 25 30 35 40 45 50 55 60 65 70 80
Cefzil Suspension (B) 90 mg/5 ml (30, 60, 90, 120 ml) (cherry); 180 mg/5ml (30, 60, 120 ml) (cherry).
APPENDIX CC.15: CEFUROXIME AXETIL (CEFTIN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
20 mg/kg/d
ml/dose bid 2.5 3.5 4.5 3 3 3.5 4 4.5 5 5.5 6 6.5
mg/5ml 125 125 125 250 250 250 250 250 250 250 250 250
Volume (ml) 50 70 90 60 60 70 80 90 100 110 120 130
30 mg/kg/d
ml/dose bid 2 3 3.5 4 5 5.5 6 7 7.5 8 9 9.5
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 40 60 70 80 100 110 120 140 150 160 180 190
Ceft in Suspension (B) 125, 250 mg/5 ml (50, 100 ml) (tutti-frutti).
APPENDIX CC.16: CEPHALEXIN (KEFLEX SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
25 mg/kg/d
ml/dose tid 1 1.5 2 2 3 3 3.5 4 4 4.5 5 5
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 30 45 60 60 90 90 105 120 120 135 150 150
25 mg/kg/d
ml/dose qid 1 1 1.5 2 2 2.5 2.5 3 3 3.5 4 4
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 40 40 60 80 80 100 100 120 120 140 160 160
50 mg/kg/d
ml/dose tid 2 3 4 4.5 5 6 7 7.5 8 9 10 10.5
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 60 90 120 135 150 180 210 225 240 270 300 315
50 mg/kg/d
ml/dose qid 2 2 3 3.5 4 4.5 5 6 6 7 7.5 8
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 80 80 120 140 160 180 200 240 240 280 300 320
Kefl ex Suspension (B)(G) <2 months: not recommended; 125, 250 mg/5 ml (100, 200 ml) (strawberry).
APPENDIX CC.17: CLARITHROMYCIN (BIAXIN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
7.5 mg/kg/d
ml/dose bid 2 3 3.5 4 5 5.5 6 7 7.5 8 9 10
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 40 60 70 80 100 110 120 140 150 160 180 200
7.5 mg/kg/d
ml/dose bid 1 1.5 2 2 2.5 3 3 3.5 4 4 4.5 5
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 20 30 40 40 50 60 60 70 80 80 90 100
Biaxin Suspension (B) <6 months: not recommended; 125, 250 mg/5 ml (50, 100 ml) (fruit-punch).
APPENDIX CC.18: CLINDAMYCIN (CLEOCIN PEDIATRIC GRANULES)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
8 mg/kg/d
ml/dose tid 1 1.5 2 2.5 3 3 3.5 4 4.5 5 5 5.5
mg/5ml 75 75 75 75 75 75 75 75 75 75 75 75
Volume (ml) 30 45 60 75 90 90 105 120 135 150 150 165
16 mg/kg/d
ml/dose tid 2.5 3 4 5 5.5 6.5 7 8 9 9.5 10.5 11
mg/5ml 75 75 75 75 75 75 75 75 75 75 75 75
Volume (ml) 75 90 120 150 165 105 210 240 270 285 315 330
Cleocin Pediatric Granules (B)(G) 75 mg/5 ml (100 ml) (cherry).
APPENDIX CC.19: DICLOXACILLIN (DYNAPEN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
12.5 mg/kg/d
ml/dose qid 2 2.5 3 3.5 4 4.5 5 6 6 7 7.5 8
mg/5ml 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5
Volume (ml) 80 100 120 140 160 180 200 240 240 280 300 320
25 mg/kg/d
ml/dose qid 3.5 4.5 6 7 8 9 10 11.5 12.5 13.5 15 16
mg/5ml 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5
Volume (ml) 140 180 240 280 320 360 400 460 500 540 600 640
Dynapen Suspension (B)(G) 6.25 mg/5 ml (80, 100 ml) (raspberry-strawberry).
APPENDIX CC.20: DOXYCYCLINE (VIBRAMYCIN SYRUP/SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
1 mg/lb/d
ml/dose qd 1.5 2 2.5 3 3.5 4 4.5 5 5.5 6 6.5 7
50 mg/5ml 50 50 50 50 50 50 50 50 50 50 50 50
Volume (ml) 15 20 25 30 35 40 45 50 55 60 65 70
1 mg/lb/d
ml/dose qd 3 4 5 6 7 8 9 10 11 12 13 14
25 mg/5ml 25 25 25 25 25 25 25 25 25 25 25 25
Volume (ml) 30 40 50 60 70 80 90 100 110 120 130 140
Vibramycin Syrup (B)(G) <8 years: not recommended; double dose fi rst day; 50 mg/5 ml (80, 100, ml) (raspberry-apple) (sulfi tes).
Vibramycin Suspension (B)(G) <8 years: not recommended; double dose fi rst day; 25 mg/5 ml (80, 100, ml) (raspberry).
APPENDIX CC.21: ERYTHROMYCIN ESTOLATE (ILOSONE SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Dose/Volume (10 days) in ml
10 mg/kg/d
ml/dose bid 3 3.5 4.5 5.5 6 7 8 9 10 5.5 6 6.5
mg/5ml 125 125 125 125 125 125 125 125 125 250 250 250
Volume (ml) 60 70 90 110 120 140 160 180 200 110 120 130
15 mg/kg/d
ml/dose bid 4 5.5 7 8 9.5 5.5 6 7 7.5 8 9 9.5
mg/5ml 125 125 125 125 125 250 250 250 250 250 250 250
Volume (ml) 80 110 140 160 190 110 120 140 150 160 180 190
20 mg/kg/d
ml/dose bid 3 3.5 4.5 5.5 6.5 7 8 9 10 11 12 13
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 60 70 90 110 120 140 160 180 200 220 240 260
25 mg/kg/d
ml/dose bid 3.5 4.5 5.5 7 8 9 10 11.5 12.5 13.5 15 16
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 70 90 110 140 160 180 200 230 250 280 300 320
Ilosone Suspension (B)(G) 125, 250 mg/5 ml (100 ml).
APPENDIX CC.22: ERYTHROMYCIN ETHYLSUCCINATE (E.E.S. SUSPENSION,
ERY-PED DROPS/SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
30 mg/kg/d
ml/dose qid 1.5 2 2 2.5 3 3.5 4 4 4.5 5 5.5 6
mg/5ml 200 200 200 200 200 200 200 200 200 200 200 200
Volume (ml) 60 80 80 100 120 140 160 160 180 200 220 240
30 mg/kg/d
ml/dose qid 1 1.5 1.5 2 2 2 2.5 2.5 3 3
mg/5ml 400 400 400 400 400 400 400 400 400
Volume (ml) 60 60 80 80 80 100 100 120 120
50 mg/kg/d
ml/dose qid 2 3 3.5 4.5 5 5.5 6.5 7 8 8.5 9 10
mg/5ml 200 200 200 200 200 200 200 200 200 200 200 200
Volume (ml) 80 120 140 180 200 220 260 280 320 340 360 400
50mg/kg/d
ml/dose qid 1 1.5 2 2 2.5 3 3 3.5 4 4.5 4.5 5
mg/5ml 400 400 400 400 400 400 400 400 400 400 400 400
Volume (ml) 40 60 80 80 100 120 140 140 160 180 180 200
Ery-Ped Drops/Suspension (B)(G) 200 mg/5 ml (100, 200 ml; fruit); 400 mg/5 ml (60, 100, 200 ml) (banana); Oral drops: 200,
400 mg/5 ml (50 ml) (fruit).
E.E.S. Suspension (B)(G) 200 mg/5 ml, 400 mg/5 ml (100 ml) (fruit).
E.E.S. Granules (B)(G) 200 mg/5 ml (100, 200 ml) (cherry).
APPENDIX CC.22: ERYTHROMYCIN ETHYLSUCCINATE (E.E.S. SUSPENSION,
ERY-PED DROPS/SUSPENSION)
APPENDIX CC.23: ERYTHROMYCIN/SULFAMETHOXAZOLE (ERYZOLE, PEDIAZOLE)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
10 mg/kg/d
ml/dose bid 3 4 5 6 6.5 7.5 8.5 9.5 10 11 12 13.5
mg/5ml 200 200 200 200 200 200 200 200 200 200 200 200
Volume (ml) 90 120 150 180 200 225 255 285 300 330 360 400
Eryzole (C)(G) <2 months: not recommended; eryth 200 mg/sulf 600 mg/5 ml (100, 150, 200, 250 ml).
Pediazole (C)(G) <2 months: not recommended; eryth 200 mg/sulf 600 mg/5 ml (100, 150, 200 ml) (strawberry-banana).
APPENDIX CC.24: FLUCONAZOLE (DIFLUCAN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/21-Day Volume (ml)
3 mg/kg/d
ml/dose qd 2 3 3.5 4 5 5.5 6 7 7.5 8 9 9.5
mg/ml 10 10 10 10 10 10 10 10 10 10 10 10
Volume (ml) 44 66 77 88 110 121 132 154 165 176 198 209
6 mg/kg/d
ml/dose qd 4 5.5 2 2 2.5 3 3 3.5 4 4 4.5 5
mg/ml 10 10 40 40 40 40 40 40 40 40 40 40
Volume (ml) 88 121 44 44 55 66 66 77 88 88 99 110
Difl ucan Suspension (B)(G) double-dose fi rst day; 10, 40 mg/5 ml (35 ml) (orange).
APPENDIX CC.25: FURAZOLIDONE (FUROXONE LIQUID)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/7-Day Volume (ml)
5 mg/kg/d
ml/dose qid 2.5 3.5 4 5 6 7 8 8.5 9.5 10 11 12
mg/15 ml 50 50 50 50 50 50 50 50 50 50 50 50
Vol 100 140 160 200 240 280 320 340 380 400 440 480
Furoxone Liquid (C)(G) double-dose fi rst day; 50 mg/15 ml (35 ml).
APPENDIX CC.26: GRISEOFULVIN, MICROSIZE (GRIFULVIN V SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/30-Day Volume (ml)
5 mg/lb/d
ml/dose day 3 4 5 6 7 8 9 10 11 12 13 14
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 90 120 150 180 210 240 270 300 330 360 390 420
Grifulvin V Suspension (C)(G) double-dose fi rst day; 125 mg/5 ml (120 ml) (orange) (alcohol 0.02%).
APPENDIX CC.27: ITRACONAZOLE (SPORANOX SOLUTION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/7-Day Volume (ml)
5 mg/kg/d
ml/dose qd 3.5 4.5 6 7 8 9 10 11.5 12.5 14 15 16
mg/ml 10 10 10 10 10 10 10 10 10 10 10 10
Volume (ml) 25 32 42 49 56 63 70 71 88 98 105 112
Sporanox V Solution (C)(G) double-dose fi rst day; 10 mg/ml (150 ml) (cherry-caramel).
APPENDIX CC.28: LORACARBEF (LORABID SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
15 mg/kg/d
ml/dose bid 2.5 3.5 4 5 3 3.5 4 4 5 5 5.5 6
mg/5ml 100 100 100 100 200 200 200 200 200 200 200 200
Volume (ml) 50 70 80 100 60 70 80 80 100 100 110 120
30 mg/kg/d
ml/dose bid 2.5 3.5 4 5 6 7 8 8.5 9.5 10 11 12
mg/5ml 200 200 200 200 200 200 200 200 200 200 200 200
Volume (ml) 50 70 80 100 120 140 160 170 190 200 220 240
Lorabid Suspension (B) 100 mg/5 ml (50, 100 ml) (strawberry bubble gum); 200 mg/5 ml (50, 75, 100 ml) (strawberry bubble gum).
APPENDIX CC.29: NITROFURANTOIN (FURADANTIN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
5 mg/kg
ml/dose qid 1.5 2.5 3 3.5 4 4.5 5 5.5 6 7 7.5 8
mg/5 ml 25 25 25 25 25 25 25 25 25 25 25 25
Volume (ml) 60 100 120 140 160 190 200 220 240 280 300 320
Furadantin Suspension (B)(G) 25 mg/5 ml (60 ml).
APPENDIX CC.30: PENICILLIN V POTASSIUM (PEN-VEE K SOLUTION,
VEETIDS SOLUTION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
25 mg/kg/d
ml/dose qid 2 2.5 3 3.5 4 4.5 5 5.5 6 7 7.5 8
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 80 90 120 140 160 180 200 220 240 280 300 320
25 mg/kg/d
ml/dose qid 1 1 1.5 2 2 2.5 2.5 3 3 3.5 4 4
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 40 40 60 80 80 100 100 120 120 140 160 160
50 mg/kg/d
ml/dose qid 2 2.5 3 3.5 4 4.5 5 6 6.5 7 7.5 8
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 80 100 120 140 160 180 200 240 260 280 300 320
Pen-Vee K Solution (B)(G) 125 mg/5 ml (100, 200 ml), 250 mg/5 ml (100, 150, 200 ml).
Veetids Solution (B)(G) 125, 250 mg/5 ml (100, 200 ml).
APPENDIX CC.31: RIMANTADINE (FLUMADINE SYRUP)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
5 mg/kg/d
ml/dose qd 3.5 4.5 6 7 8 9 10 11.5 12.5 13.5 15 16
mg/5ml 50 50 50 50 50 50 50 50 50 50 50 50
Volume (ml) 35 45 60 70 80 90 100 115 125 135 150 160
Flumadine Syrup (B) >10 years: same as adult; 50 mg/5 ml (2, 8, 16 oz) (raspberry).
APPENDIX CC.32: TETRACYCLINE (SUMYCIN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
25 mg/kg/d
ml/dose qid 1.5 2.5 3 3.5 4 4.5 5 6 6.5 7 7.5 8
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 60 100 120 140 160 180 200 240 260 280 300 320
50 mg/kg/d
ml/dose qid 3.5 4.5 6 7 8 9 10 11.5 12.5 13.5 15 16
mg/5ml 125 125 125 125 125 125 125 125 125 125 125 125
Volume (ml) 140 180 240 280 320 360 400 460 500 540 600 640
Sumycin Suspension (D)(G) <8 years: not recommended; 125 mg/5 ml (100, 200 ml) (fruit) (sulfi tes).
APPENDIX CC.33: TRIMETHOPRIM (PRIMSOL SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
5 mg/kg/d
ml/dose bid 3.5 4.5 6 7 8 9 10 11.5 12.5 13.5 15 16
mg/5ml 50 50 50 50 50 50 50 50 50 50 50 50
Volume (ml) 70 90 120 140 160 180 200 230 250 270 300 320
Primsol Suspension (C)(G) 50 mg/5 ml (50 mg/5 ml) (bubble gum) (dye-free, alcohol-free).
APPENDIX CC.34: TRIMETHOPRIM/SULFAMETHOXAZOLE (BACTRIM SUSPENSION,
SEPTRA SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
10 mg/kg/d
ml/dose bid 2 2 3 3.5 4 4.5 5 5.5 6 7 7.5 8
mg/5ml 200 200 200 200 200 200 200 200 200 200 200 200
Volume (ml) 40 40 60 70 80 90 100 110 120 140 150 160
20 mg/kg/d
ml/dose bid 4 4 6 7 8 9 10 11 12 14 15 16
mg/5ml 200 200 200 200 200 200 200 200 200 200 200 200
Volume (ml) 80 80 120 140 160 180 200 220 240 280 300 320
Bactrim Pediatric Suspension, Septra Pediatric Suspension (C)(G) trim 40 mg/sulfa 200 mg/5 ml (100 ml) (cherry) (alcohol 0.3%).
APPENDIX CC.35: VANCOMYCIN (VANCOCIN SUSPENSION)
Weight
Pounds 15 20 25 30 35 40 45 50 55 60 65 70
Kilograms 6.8 9 11.4 13.6 15.9 18.2 20.5 22.7 25 27.3 29.5 31.8
Single Dose (ml)/Frequency/Strength/10-Day Volume (ml)
40 mg/kg/d
ml/dose tid 2 2.5 3 3.5 4.5 5 5.5 6 7 7.5 8 8.5
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 60 75 90 105 135 150 165 180 210 225 240 255
40 mg/kg/d
ml/dose qid 1.5 2 2.5 3 3 3.5 4 4.5 5 5.5 6 6.5
mg/5ml 250 250 250 250 250 250 250 250 250 250 250 250
Volume (ml) 60 80 100 120 120 140 160 180 200 220 240 260
40 mg/kg/d
ml/dose tid 1 1 1.5 2 2 2.5 3 3 3.5 3.5 4 4
mg/6ml 500 500 500 500 500 500 500 500 500 500 500 500
Volume (ml) 30 30 45 60 60 75 90 90 105 105 120 120
40 mg/kg/d
ml/dose qid 1 1 1.5 1.5 1.5 2 2 2.5 2.5 3 3 3.5
mg/6ml 500 500 500 500 500 500 500 500 500 500 500 500
Volume (ml) 40 40 60 60 60 80 80 100 100 120 120 140
Vancomycin Suspension (C)(G).
t
RESOURCES
Advance for Nurse Practitioners
http://nurse-practitioners.advanceweb.com
Advanced Practice Education Associates
www.apea.com
American Association of Nurse Practitioners
www.aanp.org
American Academy of Pediatrics (AAP)

Homepage

American College of Cardiology. Th en and now: ATP III vs. IV: Comparison of ATP III
and ACC/AHA guidelines.
http://www.acc.org/latest-in-cardiology/articles/2014/07/18/16/03/then-and-nowatp-
iii-vs-iv
American Diabetes Association (ADA), Professional Diabetes Resources Online
http://professional.diabetes.org/content/clinical-practice-recommendations/
?loc=rp-slabnav
American diabetes association standards of medical care. Diabetes Care 2016, 38(Suppl. 1).
http://care.diabetesjournals.org/content/38/Supplement_1
American Family Physician
http://www.aafp.org/online/en/home.html
American Geriatrics Society 2015 Beers Criteria Update Expert Panel. (2015). American
geriatrics society 2015 updated Beers Criteria for potentially inappropriate medication
use in older adults. Journal of the American Geriatrics Society, 63(11), 2227–2246.
American Headache Society
www.americanheadachesociety.org
American Pain Society
http://americanpainsociety.org/
American Pharmacists Association. (2015). Pediatric and neonatal dosage handbook:
A universal resource for clinicians treating pediatric and neonatal patients (22nd ed.).
Hudson, OH: Lexicomp.
CDC: Morbidity and Mortality Weekly Report (MMWR)
http://www.cdc.gov/mmwr/mmwr_wk.html
CDC 2015 Sexually Transmitted Diseases Treatment Guidelines
http://www.cdc.gov/std/tg2015/default.htm
Centers for Disease Control and Prevention
www.cdc.gov
Centers for Disease Control and Prevention. (2016). Facts about ADHD.
www.cdc.gov/ncbddd/adhd/facts.html
Chow, A. W., Benninger, M. S., Brook, I., Brozek, J. L., Goldstein, E. J., Hicks, L. A., . . .
File, T. M., Jr., Infectious Disease Society of America. (2012). IDSA clinical practice
guideline for acute and bacterial rhinosinusitis in children and adults. Clinical Infectious
Diseases, 54(8), e72–e112.
Clinician Reviews
http://www.clinicianreviews.com
Consultant 360
http://www.consultant360.com/home
Daily Med: NIH. US Library of Medicine
https://dailymed.nlm.nih.gov/dailymed/index.cfm
Domino, F. J., Baldor, R. A., Golding, J., & Stephens, M. B. Th e 5-minute clinical consult
standard 2016. Philadelphia, PA: Wolters Kluwer.
DRUGS.COM
www.drugs.com
DRUGS at FDA: FDA Approved Drug Products
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm
Engorn, B., & Flerlage, J. (Eds.). (2015). Th e Harriet Lane handbook: A handbook for
pediatric house offi cers (20th ed.). Philadelphia, PA: Elsevier.
epocrates
https://online.epocrates.com/drugs
eMPR: Monthly Prescribing Reference (new FDA approved products, new generics,
new drug withdrawals, safety alerts)

Home

FDA: Recalls, Market Withdrawals, and Safety alerts
http://www.fda.gov/Safety/Recalls/default.htm
Gilbert, D. N., Chambers, H. F., Eliopoulos, G. M., Saag, M. S., & Pavla, A. T. (2016). Th e
Sanford guide to antimicrobial therapy, 2016. Sperryville, VA: Antimicrobial Th erapy.
Handbook of Antimicrobial Th erapy (20th ed.). (2015). New Rochelle, NY: Th e Medical
Letter.
International Diabetes Federation (IDF) Clinical Practice Guidelines
http://www.idf.org/guidelines
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C.,
Handler, J., . . . Ortiz, E. (2014). 2014 evidence-based guidelines for the management of
high blood pressure in adults: Report from the panel members appointed to the eighth
joint national committee (JNC 8). Journal of the American Medical Association, 311(5),
507–520.
JNC 8 Guideline Summary. Pharmacist’s Letter/Prescriber’s Letter

Journal of the American Academy of Nurse Practitioners
https://www.aanp.org/publications/jaanp
Journal of the American Medical Association (JAMA) Internal Medicine
http://archinte.jamanetwork.com/journal.aspx
Journal of the American Geriatrics Society
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1532-5415
Lieberthal, A. S., Carroll, A. E., Chonmaitree, T., Ganiats, T. G., Hoberman, A., Jackson,
M. A., . . . Tunkel, D. E. (2013). Th e diagnosis and management of acute otitis media.
Pediatrics, 131(3), e964–e999.
Mandell, L. A. Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean,
N. C., . . . Whitney, C. G. (2007). Infectious diseases society of America/American
Th oracic Society consensus guidelines on the management of community-acquired
pneumonia in adults. Clinical Infectious Diseases, 44(Suppl. 2), S27–S72.
https://enp-network.s3.amazonaws.com/NPA_Long_Island/pdf/Pneumonia.pdf
McMillan, J. A., Lee, C. K. K., Siberry, G. K., & Carroll, K. C. (2013). Th e Harriet Lane
handbook of pediatric antimicrobial therapy. Philadelphia, PA: Elsevier Saunders.
MedlinePlus
https://www.nlm.nih.gov/medlineplus/ency/article/000165.htm
MedPage Today
http://www.medpagetoday.com
Medscape
http://www.medscape.com
National Academy of Medicine

Home

National Cholesterol Education Program Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel IV, 2012).
http://circ.ahajournals.org/content/circulationaha/106/25/3143.full.pdf
National Heart Lung and Blood Institute (NHLBI)
http://www.nhlbi.nih.gov
New England Journal of Medicine (NEJM) Journal Watch General Medicine
http://www.jwatch.org/general-medicine
Pharmacist’s Letter
www.pharmacistsletter.com
Physician’s Desk Reference (PDR)
http://www.pdr.net
Prescriber’s Letter
http://prescribersletter.therapeuticresearch.com/pl/sample.aspx?cs=&s=PRL&
AspxAutoDetectCookieSupport=1
Psychopharmacology
http://link.springer.com/journal/213
Reference for Interpretation of Hepatitis C Virus (HCV) Test Results
www.cdc.gov/hepatitis
RxLIST
http://www.rxlist.com/script/main/hp.asp
RxLIST: Drugs A-Z
http://www.rxlist.com/drugs/alpha_a.htm
Sanford Guide Web Edition
https://webedition.sanfordguide.com
Solutions for Safer ER/LA Opioid Prescribing in a New Era of Health Care. American
Nurses Credentialing Center, Post Graduate Institute of Medicine
www.cmeuniversity.com
Th e American Congress of Obstetrics and Gynecology (ACOG)
http://www.acog.org
Th e American Geriatric Society
http://www.americangeriatrics.org
Th e Handbook of Antimicrobial Th erapy (20th ed.). Th e Medical Letter
Th e Journal for Nurse Practitioners
www.elsevier.com/locate/tjnp
Th e Medical Letter on Drugs and Th erapeutics (subscription)
http://secure.medicalletter.org
Th e Nurse Practitioner Journal
www.tnpj.com
Th ird Report of the National Cholesterol Education Program (NCEP) Expert Panel
on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III) fi nal report.
http://www.ncbi.nlm.nih.gov/pubmed/12485966
Treatment Guidelines [Annual Volume]: Th e Medical Letter
Updated CDC guidance: Superbugs threaten hospital patients. Medscape Education
Clinical Briefs (March 31, 2016).
http://www.medscape.org/viewarticle/859361?nlid=105320_2713&src=wnl_
cmemp_160523_mscpedu_nurs&impID=1106718&faf=1
U.S. Pharmacist Weekly Newsletter
http://www.uspharmacist.com
Wald, E. R., Applegate, K. E., Bordley, C., Darrow, D. H., Glode, M. P., Marcy, S. M., . . .
Weinberg, S. T., American Academy of Pediatrics. (2013). Clinical practice guidelines
for the diagnosis and management of acute bacterial sinusitis in children 1 to 18 years.
Pediatrics, 132(1), e262–280.
http://www.ncbi.nlm.nih.gov/pubmed/23796742
WebMD: Drugs and Medications A to Z. Latest Drug News
http://www.webmd.com/drugs